Podcasts about Cat

Russia's expanding nuclear arsenal, matching U.S. drug prices with Europe's, Federal agencies backing farmers' right to repair, and the fatal takeoff of UPS flight 2976. Plus, Albert Mohler on the borderless illusion, Larry the Cat at Number 10 Downing Street, and the Tuesday morning newsSupport The World and Everything in It today at wng.org/donateAdditional support comes from Pensacola Christian College. Academic excellence, biblical worldview, affordable cost. go.pcci.edu/worldFrom Ridge Haven Camp in North Carolina and Iowa. Summer Camp registration open now at ridgehaven.orgAnd from Dordt University, where the MSN–Family Nurse Practitioner program prepares nurses for Christ-centered, family-focused care. Dordt.edu

Cat and Pat are back and better than ever with a new episode of Seek Treatment for your listening ears, eyes, hearts, etc. Pat shares about his introduction to the world of Transcendental Meditation, while Cat fills Pat in on her latest adventure in Louisiana. Also discussed are body scans, the trials and tribulations of being alive, as well as an important correction regarding the frequency of Pat's haircuts.Watch the full episode on our YouTube and follow below!Show Instagram: https://www.instagram.com/seektreatmentpodShow Tiktok: https://www.tiktok.com/@seektreatmentpodCat: https://www.instagram.com/catccohenPat: https://www.instagram.com/patreegsSeek Treatment is a production of Headgum Studios. Our producer is Allie Kahan. Our executive producer is Emma Foley. The show is engineered and edited by Richelle Chen. The show art was created by Carly Jean Andrews.Like the show? Rate Seek Treatment on Spotify and Apple Podcasts and leave a review.Advertise on Seek Treatment via Gumball.fmSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Was my mouth created by the US government?/Can you hack a ghost encounter?   Fan Art by Johnny Krimson   I will be speaking at the Oregon Ghost Conference March 27-29 2026 For more info, tickets, and more: http://www.oregonghostconference.com/   Patreon (Get ad-free episodes, Patreon Discord Access, and more!) https://www.patreon.com/user?u=18482113 PayPal Donation Link https://tinyurl.com/mrxe36ph MERCH STORE!!! https://tinyurl.com/y8zam4o2 Amazon Wish List https://www.amazon.com/hz/wishlist/ls/28CIOGSFRUXAD?ref_=wl_share Dead Rabbit Radio Archive Episodes https://deadrabbitradio.blogspot.com/2025/07/ episode-archive.html https://archive.ph/UELip Dead Rabbit Radio Recommends Master List https://letterboxd.com/dead_rabbit/list/dead-rabbit-radio-recommends/ Links: EP 422 - The Unthinkable Madness At The Kitchen Table https://deadrabbitradio.libsyn.com/ep-422-the-unthinkable-madness-at-the-kitchen-table EP 551 - Earth First! (Super Soldier episode) https://deadrabbitradio.libsyn.com/ep-551-earth-first EP 614 - Does Drug Use Turn You Into A Demonic Portal? (Super Soldier episode) https://deadrabbitradio.libsyn.com/ep-614-does-drug-use-turn-you-into-a-demonic-portal EP 54 - Super Soldier John Stormm (Super Soldier episode) https://deadrabbitradio.libsyn.com/ep-54-super-soldier-john-stormm EP 55 - The Death Of A Conspiracy Theorist (Super Soldier episode) https://deadrabbitradio.libsyn.com/ep-55-the-death-of-a-conspiracy-theorist EP 577 - Unleash The Power Of Rhino Balls! (Super Soldier episode) https://deadrabbitradio.libsyn.com/ep-577-unleash-the-power-of-rhino-balls EP 825 - Kevin Wikse The Pagan Strongman Vs The Men In Black! (Super Soldier episode) https://deadrabbitradio.libsyn.com/ep-825-kevin-wikse-the-pagan-strongman-vs-the-men-in-black EP 449 - Is The GATE Program Fighting The Future? (Super Soldier episode) https://deadrabbitradio.libsyn.com/ep-449-is-the-gate-program-fighting-the-future EP 201 - The Dragon (Speech Therapy/GATE Program episode) https://deadrabbitradio.libsyn.com/ep-201-the-dragon EP 677 - Blue Canary In The Outlet On The Starship (Super Soldier episode) https://deadrabbitradio.libsyn.com/ep-677-blue-canary-in-the-outlet-on-the-starship EP 888 - The Battlefield On The Edge Of Yesterday https://deadrabbitradio.libsyn.com/ep-888-the-battlefield-on-the-edge-of-yesterday What is the scariest paranormal experience you have had or heard from someone you believe wouldn't lie? (Imitate Ghost Death Man Falls Off Roof Visits New Tenant In Dream Shadowman Walking In The Light story) https://www.reddit.com/r/AskReddit/comments/1zm8vn/comment/cfwjlu8/ Archive https://archive.ph/VzcXw Need help deciphering an experience! (Los Angeles 110 Music Producer Ghost Girl Dancing In Backseat Of Car story) https://www.reddit.com/r/ParanormalEncounters/comments/1qudtm3/comment/o3dy6bz/?force-legacy-sct=1 Archive https://archive.ph/uD1pj   ------------------------------------------------ Logo Art By Ash Black Opening Song: "Atlantis Attacks" Closing Song: "Bella Royale" Music By Simple Rabbitron 3000 created by Eerbud Thanks to Chris K, Founder Of The Golden Rabbit Brigade Dead Rabbit Archivist Some Weirdo On Twitter AKA Jack YouTube Champ: Stewart Meatball Reddit Champ: TheLast747 The Haunted Mic Arm provided by Chyme Chili Discord Mods: Mason, Rudie Jazz Forever Fluffle: Cantillions, Samson, Gregory Gilbertson, Jenny the Cat http://www.DeadRabbit.com Email: DeadRabbitRadio@gmail.com Facebook: www.Facebook.com/DeadRabbitRadio TikTok: https://www.tiktok.com/@deadrabbitradio Dead Rabbit Radio Subreddit: https://www.reddit.com/r/DeadRabbitRadio/ Paranormal News Subreddit: https://www.reddit.com/r/ParanormalNews/ Mailing Address Jason Carpenter PO Box 1363 Hood River, OR 97031 Paranormal, Conspiracy, and True Crime news as it happens! Jason Carpenter breaks the stories they'll be talking about tomorrow, assuming the world doesn't end today. All Contents Of This Podcast Copyright Jason Carpenter 2018 - 2026    

In this episode of the PurrPodcast, Dr. Susan Little and Dr. Jolle Kirpensteijn welcome Dr. Katie Tolbert from Texas A&M University for a practical and science-driven discussion on chronic pancreatitis in cats, with a strong focus on the critical role nutrition plays in long-term management. Together, they explore why chronic pancreatitis is often subtle and multifactorial, how dietary composition influences inflammation and gastrointestinal stability, and—perhaps most importantly—how treats, supplements, and small “extras” can quietly unbalance a carefully formulated therapeutic diet. Even a few treats can dilute nutrient density, disrupt macronutrient balance, and compromise clinical progress, making owner education and dietary consistency essential parts of successful case management. This episode is packed with clinical pearls for veterinarians who want to optimize nutritional strategies, improve compliance, and better understand how precision feeding can significantly impact outcomes in feline chronic pancreatitis.Thanks for tuning in to the Purr Podcast with Dr. Susan and Dr. Jolle!If you enjoyed today's episode, don't forget to subscribe, rate, and leave us a review—it really helps other cat lovers and vet nerds find the show. Follow us on social media for behind-the-scenes stories, cat trivia, and the occasional bad pun. And remember: every day is better with cats, curiosity, and maybe just a little purring in the background. Until next time—stay curious, stay kind, and give your cats an extra chin scratch from us. The Purr Podcast – where feline medicine meets feline fun.

Episode 85 kicks off with Carl railing against the Winter Olympics being held in Italy -- not because he hates pasta or gondolas, but because the time difference and the internet have completely destroyed the magic. After the usual weekend riff, the crew runs through a packed News of the Week: The Mansfield Inn is officially emptied after the vacate order, a major roundabout project is coming to Lexington-Springmill and Home Roads and a gang-related case ends in a prison sentence. Then the show takes a sharp turn into the mysterious and fascinating: Carl and the guys sit down with Maddalena, a Mansfield mom of four and independent researcher/translator exploring ancient Greek biblical texts through a poetic, Hellenic lens. She walks through how she got into the work, what separates her approach from traditional biblical scholarship and what she believes gets lost across time, translation and power. It’s an open-minded deep dive into language, symbolism, myth, early Christianity and the kinds of interpretations that challenge what many people assume the text “has to mean.” This episode is powered by the great folks at Relax, It's Just Coffee. Related links: Follow Maddalena on Instagram Follow Dr. Ammon on YouTube Links to the Soma library Orphic Vox Glossary Sabachthani Mark 14:51-52 Queen Medea News of the Week links Vacate order fulfilled: Last tenant leaves Mansfield Inn in Mifflin Township Bids sought for roundabout at Lexington-Springmill/Home Road intersection Mansfield police CAT team credited as gang member pleads guilty in court Be a Source Member for unlimited access to local, independent journalism. Download our new mobile app. Full intro song (produced by AI) here.Support the show: https://richlandsource.com/membersSee omnystudio.com/listener for privacy information.

Trong những thời điểm chính trị đầy biến động, sự ổn định đôi khi lại đến từ bốn chân, bộ ria mép và niềm yêu thích những giấc ngủ ngắn. Larry the Cat vừa kỷ niệm 15 năm đảm nhiệm vai trò “Chánh bắt chuột” chính thức của Chính phủ Anh và là “đệ nhất mèo” không chính thức", một sự hiện diện đầy trấn an tại 10 Downing Street, nơi chú đã phục vụ dưới thời sáu đời Thủ tướng.

Join Darren Lekkerkerker, Portfolio Manager, for an in-depth look at what's driving North American equity markets today—and where opportunities may emerge next. Plus, get the latest updates on Fidelity North American Equity Class and Fidelity American Equity Fund, including insights to help you position portfolios in a shifting market environment. Recorded on February 10, 2026. At Fidelity, our mission is to build a better future for Canadian investors and help them stay ahead. We offer investors and institutions a range of innovative and trusted investment portfolios to help them reach their financial and life goals. Fidelity mutual funds and ETFs are available by working with a financial advisor or through an online brokerage account. Visit fidelity.ca/howtobuy for more information. For a fifth year in a row, FidelityConnects by Fidelity Investments Canada was ranked #1 podcast by Canadian financial advisors in the 2025 Environics' Advisor Digital Experience Study.   --   Joignez-vous à Darren Lekkerkerker, gestionnaire de portefeuille, qui discutera en détail des facteurs qui stimulent les marchés nord-américains et des occasions qui pourraient se présenter. De plus, obtenez les dernières mises à jour sur la Catégorie Fidelity Actions nord-américaines et le Fonds Fidelity Actions américaines, y compris des analyses pour vous aider à positionner les portefeuilles dans un contexte en évolution. Date : 10 février 2026 Chez Fidelity, notre mission consiste à aider le public investisseur canadien à se bâtir un meilleur avenir et à rester à l'avant-garde. Nous offrons aux particuliers et aux institutions une gamme de portefeuilles de placement innovants et fiables pour les aider à atteindre leurs objectifs financiers et personnels. Les fonds communs de placement et les FNB de Fidelity sont offerts par l'intermédiaire des conseillers et conseillères en placements et de comptes de courtage en ligne. Pour de plus amples renseignements, visitez fidelity.ca/commentinvestir. Les baladodiffusions DialoguesFidelity se sont classées au premier rang pour une cinquième année consécutive lors du sondage 2025 d'Environics sur l'expérience numérique des conseillers et conseillères en placements au Canada.

Meditaciones y reflexiones para hacer la oración especialmente dirigidas a jóvenes. || Visita nuestra página WEB y lee los testimonios, artículos y suscríbete a los Podcast diarios de rezarhoy en: https://www.jovenescatolicos.es/ || Sigue el canal de Jóvenes Católicos en WhatsApp: https://whatsapp.com/channel/0029VaDQN04LY6d1sgDXEK3s || Colabora con tu generosidad: https://www.jovenescatolicos.es/socios/ || Pásate por nuestra cuenta de Instagram: https://www.instagram.com/catolicos_es/ || X (Twitter): https://twitter.com/catolicos_es || Facebook: https://www.facebook.com/Catolicos.es/ || Pásate por la página web de Cobel Ediciones: http://www.cobelediciones.com/ ||

In this episode of Gangland Wire, host Gary Jenkins, retired Kansas City Police Intelligence Unit detective, steps outside traditional Mafia territory and into a shadowy world just as dangerous—and just as fascinating: the international theft of ultra-rare automobiles.  Gary is joined by author Stayton Bonner, former senior editor at Rolling Stone, and legendary car-recovery specialist Joe Ford, the real-life figure behind Bonner's book The Million Dollar Car Detective. At the center of the story is a breathtaking pre-World War II automobile—the Talbot-Lago Teardrop Coupé—once described as the most beautiful car in the world. Stolen from a Milwaukee industrialist's garage in 2001, the car vanished into the international underground of elite collectors, forged paperwork, and high-stakes deception. Joe Ford explains how he became the go-to investigator when rare cars worth millions disappear—and why stolen vehicles are far harder to recover than stolen art. What follows is a years-long global hunt involving disgruntled mechanics, fabricated titles, shell corporations, Swiss intermediaries, and a billionaire buyer now locked in civil litigation. Bonner adds rich historical context, tracing the car's glamorous past—from European aristocracy to Hollywood royalty—and exposing how loneliness, obsession, and greed often surround these legendary machines. The conversation expands into other notorious cases, including the disappearance of the original James Bond Aston Martin from Goldfinger, and how wealthy collectors sometimes knowingly harbor stolen artifacts. This episode is a true-crime story without guns or gangs—but filled with deception, betrayal, and the relentless pursuit of justice across borders. If you love investigative work, high-end crime, and stories that feel like James Bond meets Gone in 60 Seconds, this one's for you.

AITA: For charging my friend for a cleaning service? DIRT ALERT: Nancy Guthrie update, and Larry the Cat's 15th year on the job at UK's chief mouserSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Even baby dinosaurs can have a huge impact on animation.In 1988, three Hollywood titans, Steven Spielberg, George Lucas, and Don Bluth, came together to create what would become one of the most emotionally devastating animated films ever made, and it is the second movie to celebrate this podcast's seventh birthday.The Land Before Time wasn't just another dinosaur movie: it was an ambitious attempt to recapture the magic of Bambi for a new generation, complete with a mother's death scene that traumatized millions of kids and made it a cultural touchstone. Despite the cutting of over ten minutes of footage deemed too scary, the film still pulled no punches in its portrayal of loss, survival, and the harsh realities of a prehistoric world.What makes The Land Before Time so enduring isn't just nostalgia, it's the film's willingness to treat young audiences with respect, addressing grief and fear head on.Working with both Spielberg and Lucas wasn't exactly the dream scenario Bluth expected it to be, though, and the partnership between Amblin & Sullivan Bluth would, like the dinosaurs they depicted, quickly become extinct. Despite this, The Land Before Time remains a masterclass in emotional storytelling that still resonates nearly four decades later.Support Verbal DioramaLoved this episode? Here's how you can help:⭐ Leave a 5-star review on your podcast app

What happens when sobriety stops being your whole identity—but honesty still matters? In this episode, I sit down with journalist, creator, and host Cat Greenleaf for a wide-ranging conversation about sobriety without performative seriousness, the exhaustion of high-functioning addiction, and the courage it takes to walk away from something—even when you're good at it. Cat is the creator and former host of Talk Stoop, a groundbreaking celebrity interview show that paved the way for digital content before platforms like TikTok even existed. Now she hosts the Soberness podcast, where she brings her signature warmth and realness to conversations about recovery with celebrities and public figures navigating sobriety in the spotlight. We talk about shame, ambition, therapy skepticism, creative identity, aging, and why "go where the water's warm"—a piece of advice from Brooke Shields that Cat received 16 years ago—might be the most trustworthy life guidance there is. If you've ever looked successful on the outside while quietly unraveling on the inside, or if you've felt that nudge that something in your life is done, this episode is for you. In This Episode: What high-functioning addiction actually looks like and how Cat knew it wouldn't go well from the start Why she spent 10 years sober without attending AA meetings The moment at a wedding that changed everything "I hate therapy" (and why that's perfectly okay) Why Cat is shifting her Soberness podcast from recorded interviews to live storytelling events The "be kind" tattoo story—and why she's having it removed How to know when it's time to walk away from something that's no longer working People's commitment to their own joy (and what that means for the rest of us) Guest: Cat Greenleaf is a journalist, creator, and host of the Soberness podcast. She's the creator of Talk Stoop, where she interviewed celebrities on her Brooklyn stoop before digital content became what we know it as today. She's currently pursuing her master's in forensic mental health counseling and has been working with incarcerated individuals for the past two years. Cat has been sober for 12 years. Connect with Cat: The Soberness Podcast: Soberness Podcast | Celebrity Interviews with Cat Greenleaf on Recovery and Sobriety Instagram: Soberness (@sobernesspodcast) • Instagram profile YouTube: Soberness Podcast with Cat Greenleaf Resources Mentioned: Talk Stoop (Cat's groundbreaking celebrity interview show) Brooke Shields' advice: "Go where the water's warm" The Algonquin Hotel (Cat's base for live Soberness events in NYC) Subscribe to Don't Cut Your Own Bangs: New episodes drop regularly with interviews, solo casts, and all the hope you need to keep going. Connect with Danielle: Website: Indianapolis Mental Health Educator, Speaker & Therapist for Women Instagram: Danielle Ireland | Therapist (@dontcutyourownbangs) • Instagram profile The Treasured Journal: Treasured: Self Discovery Journal for Women - Guided Journal Mental Health Wrestling a Walrus (Children's Book): Wrestling a Walrus | Emotional Regulation Book for Big Feelings Don't Cut Your Own Bangs is a cozy corner of the internet for high-functioning humans with big feelings — the capable ones who get things done but quietly wonder if something's missing. If you're the unicorn in a power suit (or a perfectly neutral sweater), building a life that looks "right" on paper but still craving something freer and more alive — you're in the right place. Hosted by therapist and author Danielle Ireland, this show feels like sitting on the couch with your best friend — if your best friend happened to be a therapist. Together, we untangle burnout, anxiety, pressure, and comparison, and learn how to turn emotions into allies instead of obstacles. This is a space for comfort, community, clarity — and a few laughs along the way. Because you deserve calm without having to earn it.  

The Unexpected Morning ep.814 Rick Kennett is a life long resident of Melbourne, Australia. While a bounder and a cad to the populace in general he is nevertheless a good friend to next door's white Tom who, in a fit of originality, he calls Cat. Rick was recently published in the Canadian magazine Weird Horror, and a reissue of his co-authored Carnacki the Ghost Finder pastiches, 472 Cheyne Walk, will be issued soon from Cathaven Press. "The Unexpected Morning" has a lot more reality in it than he cares to admit. Including a real ghost.   More TTTV stories by Rick Kennett: https://talltaletv.com/tag/rick-kennett/   ---- Listen Elsewhere ---- YouTube:  https://www.youtube.com/c/TallTaleTV Website: http://www.TallTaleTV.com   ---- Story Submission ---- Got a short story you'd like to submit? Submission guidelines can be found at http://www.TallTaleTV.com   ---- About Tall Tale TV ---- Hi there! My name is Chris Herron and I'm an audiobook narrator. In 2015, I suffered from poor Type 1 diabetes control which lead me to become legally blind for almost a year. The doctors didn't give me much hope, predicting an 80% chance that I would never see again. But I refused to give up and changed my lifestyle drastically. Through sheer willpower (and an amazing eye surgeon) I beat the odds and regained my vision. During that difficult time, I couldn't read or write, which was devastating as they had always been a source of comfort for me since childhood. However, my wife took me to the local library where she read out the titles of audiobooks to me. I selected some of my favorite books, such as the Disc World series, Name of the Wind, Harry Potter, and more, and the audiobooks brought these stories to life in a way I had never experienced before. They helped me through the darkest period of my life and I fell in love with audiobooks. Once I regained my vision, I decided to pursue a career as an audiobook narrator instead of a writer. That's why I created Tall Tale TV, to support aspiring authors in the writing communities that I had grown to love before my ordeal. My goal was to help them promote their work by providing a promotional audio short story that showcases their writing skills to readers. They say the strongest form of advertising is word of mouth, so I offer a platform for readers to share these videos and help spread the word about these talented writers. Please consider sharing these stories with your friends and family to support these amazing authors. Thank you!   ---- legal ---- All stories on Tall Tale TV have been submitted in accordance with the terms of service provided on http://www.talltaletv.com or obtained with permission by the author. All images used on Tall Tale TV are either original or Royalty and Attribution free. Most stock images used are provided by http://www.pixabay.com , https://www.canstockphoto.com/ or created using AI. Image attribution will be declared only when required by the copyright owner. Common Affiliates are: Amazon, Smashwords

Welcome in and welcome back to this week's 5Aside! The show where we discuss 5 things aside from the most recent 5 stripes match! On this episode Glenn, Cat, Jennifer and Amy pick their top 5 kits for the start of the 2026 season and we also take a look at our roster as it currently stands before we kick off the season this Saturday against Skyline Chili FC! Thank you as always to MasonMillChiro.com Call 404-321-0082 to book your appointment today! Join the Atlanta United Fan TV Discord

Welcome in and welcome back to this week's 5Aside! The show where we discuss 5 things aside from the most recent 5 stripes match! On this episode Glenn, Cat, Jennifer and Amy pick their top 5 kits for the start of the 2026 season and we also take a look at our roster as it currently stands before we kick off the season this Saturday against Skyline Chili FC! Thank you as always to MasonMillChiro.com Call 404-321-0082 to book your appointment today! Join the Atlanta United Fan TV Discord

Meditaciones y reflexiones para hacer la oración especialmente dirigidas a jóvenes. || Visita nuestra página WEB y lee los testimonios, artículos y suscríbete a los Podcast diarios de rezarhoy en: https://www.jovenescatolicos.es/ || Sigue el canal de Jóvenes Católicos en WhatsApp: https://whatsapp.com/channel/0029VaDQN04LY6d1sgDXEK3s || Colabora con tu generosidad: https://www.jovenescatolicos.es/socios/ || Pásate por nuestra cuenta de Instagram: https://www.instagram.com/catolicos_es/ || X (Twitter): https://twitter.com/catolicos_es || Facebook: https://www.facebook.com/Catolicos.es/ || Pásate por la página web de Cobel Ediciones: http://www.cobelediciones.com/ ||

The ASX 200 finished up 20 to 8937 (0.2%) despite the big miners falling on lower iron ore prices.  Banks pushed up slightly, NAB down 1.0% and ANZ off 3.1% with the Big Bank Basket up to $304.06 (%). Other financials were mixed, NWL rallied 3.7% and GQG up 5.5% with ZIP forging ahead up 5.5%. MQG rose 0.4%. Insurers better. Industrials were solid, WES up 1.2% with retail better as JBH rose 7.5% on better results, ALL up 2.2% and WOW and COL slightly firmer. ‘Old skool' platform stocks also doing ok, REA up 2.9% and CAR up 2.7%. Tech stocks were the standouts after a torrid week last week. WTC up 12.9% and XRO rallying 7.6% with the All-Tech Index up 4.0%. 360 rose 6.8% with CAT also doing well, up 5.1%. REITs firmed, GMG up 0.6%.In resources, the big three iron ore miners sold off as prices dipped below $100. Gold miners were bid up, GMD up 7.4% on a takeover of MAU. NEM gained 2.7% and WGX up 1.4%. Lithium stocks slightly firmer. VUL up 3.1%.  Oil and gas stocks rose, uranium stocks glowed hotter, PDN up 1.4% and BMN up 4.6%.In corporate news, TWE fell 5.2% after a disappointing result and a cut of the dividend. JBH rose 7.5% on a beat. ASB jumped 19.5% after a disastrous day Friday, QUB rose 3.3% after Macquarie went binding on its takeover at 520c. A2M creamed it up 6.8% after a better second half and ANN bounced 3.8% on cost cutting effort paying off.Nothing on the economic front.US Futures up slightly in birthday celebrations.—Marcus Today – Daily Market InsightsMarcus Today provides clear, practical commentary for self-directed investors – covering markets, portfolios, education, and decision-making without the noise.If you'd like to go further:Start a free 14-day trial of Marcus Todayhttp://bit.ly/mt-trial-podcastJoin Marcus TodayUse code MTPODCAST for 10% offhttp://bit.ly/mt-join-podcast-offerMT20 – Managed ETF PortfolioA professionally managed portfolio run by Marcus Padley and the team, using ASX-listed ETFs with active market timing.http://bit.ly/mt20-podcastPrinciples – How We Think About InvestingA short video series on timing, behaviour, and decision-making. No stock tips.http://bit.ly/mt-principles-podcast—DisclaimerThis podcast is general information only and does not consider your personal circumstances. It is not personal financial advice.

Los siete domingos de san José invitan a recorrer, semana a semana, los momentos de luz y de sombra en la vida del Santo Patriarca. Al contemplar sus alegrías y dificultades, esta costumbre de la Iglesia nos ayuda a crecer en intimidad con él y nos prepara para celebrar su solemnidad el 19 de marzo. || Meditaciones y reflexiones para hacer la oración especialmente dirigidas a jóvenes. || Pásate por nuestra WEB y lee los testimonios, artículos y suscríbete a los Podcast diarios de rezarhoy en: https://www.jovenescatolicos.es/Sigue el canal de Jóvenes Católicos en WhatsApp: https://whatsapp.com/channel/0029VaDQN04LY6d1sgDXEK3sPásate por nuestra cuenta de Instagram: https://www.instagram.com/catolicos_es/Twitter: https://twitter.com/catolicos_esFacebook: https://www.facebook.com/Catolicos.es/Pásate por la página web de Cobel Ediciones: http://www.cobelediciones.com/

The corn is aggrieved, the empire is diseased, there is a darkness reaching like rust into everything around us. Breath deep, Tumblehomies, this may be the last fresh air we ever taste. Keep a steady speed going up or down the hill, and the gold medal in skijour will be jours. Source material: The Manitous, Cat's Cradle, Andor.  L'Etoile du Nord! Playlist  Subscribe: Patreon Spotify iTunes YouTube Stitcher Google Play Soundcloud  

Your intrepid hosts, Ben Creighton and Kenny Windorski, have meticulously ranked Batman: The Animated Series, The New Batman Adventures, Superman: The Animated Series, Matlock, Batman Beyond, Murder She Wrote, and Justice League with unimpeachable SCIENCE! After a science-free year with Static Shock, now we're back to SCIENCE with Justice League Unlimited!Join us on Discord at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠bit.ly/LandOfTheBlind⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Get your own Justice League Cold Open Bingo card and play along: ⁠⁠⁠⁠⁠⁠⁠⁠https://bingobaker.com/#64c7bfe36e604708⁠⁠⁠⁠⁠⁠⁠⁠The List:1.) Question Authority 2.) The Doomsday Sanction3.) A Better World4.) Starcrossed5.) Panic in the Sky6.) Divided We Fall7.) Epilogue8.) Fearful Symmetry9.) Secret Origins10.) Murder She Wrote - The Death of Sherlock Holmes11.) Task Force X12.) Flashpoint13.) Savage Time14.) Kid Stuff15.) A Knight of Shadows16.) In Blackest Night17.) The Enemy Below18.) Hereafter19.) Wild Cards20.) The Cat and the Canary21.) For the Man Who Has Everything22.) Initiation23.) Comfort and Joy24.) Only a Dream25.) Double Date26.) The Greatest Story Never Told27.) The Once and Future Thing28.) Eclipsed29.) Flash and Substance30.) Shadow of the Hawk31.) Tabula Rasa32.) Twilight33.) The Brave and the Bold34.) Paradise Lost35.) Clash36.) Ultimatum37.) The Ties That Bind38.) Legends39.) Injustice For All40.) War World41.) The Balance42.) Hunter's Moon43.) Chaos at the Center of the Earth44.) The Return45.) This Little Piggy46.) I Am Legion47.) Secret Society48.) Maid of Honor49.) Hawk & Dove50.) Fury51.) Hearts and Minds52.) The Terror Beyond53.) Metamorphosis54.) To Another Shore55.) Wake the Dead56.) Dark Heart

The Path to Pet Wellness: Holistic Approaches for a Longer, Happier Life." Grandpa Bill explores holistic strategies to enhance your pet's well-being, drawing insights from expert pet health advocate Grandpa Bill. It covers topics like nutrition, supplements, and the BEAM approach to pet health, providing practical tips for pet owners.Dr. Jeff Feinman's “BEAM” acronym — Behavior, Energy, Appetite, Mood — encapsulates a holistic view of pet health. Grandpa Bill's experience with his cats shows how focusing on these areas can extend their lifespan and improve quality of life.Balance: Ensure your pet's diet supports physical and emotional balanceEnergy: Promote activity and prevent lethargy through diet and environmental enrichmentAppetite: Monitor for changes; a healthy appetite indicates good healthMood: Observe behavioral signs; a cheerful pet is a healthy pet#PetWellness, #,#BEAMFramework, #PetNutrition, #HolisticPetCare,Grandpa Bill's own pets serve as a testament to holistic care's effectiveness. His cats, Brady and Brody, reached ages well beyond average thanks to thoughtful nutrition, supplements, and attentive observation. His proactive approach emphasizes that small, consistent actions can lead to significant health benefits.He also highlights the importance of hydration, giving his cats tourmaline spring water, and adapting diets based on ongoing assessments — key ingredients for a thriving pet.Supporting your pet's health holistically is a loving investment that pays off in vitality and longevity. Start by integrating fresh foods into their diet, observe their responses carefully, and consult experienced holistic veterinarians when needed. Remember, small daily choices—like offering healthy snacks and ensuring proper hydration—can make a big differenceJoin upcoming webinars and talks on pet wellness, such as Grandpa Bill's scheduled sessions, to learn more about natural approaches to caring for your furry friend.BEAM stands for Behavior, Energy, Appetite, and Mood — key factors to assess and support for overall pet wellness.Start with small amounts of fresh vegetables like cabbage or carrots, finely chopped or pulsed, and gradually observe how your pet responds.Supplements can support health, especially for older pets, but should always be used under veterinary guidance tailored to your animal's needs.Absolutely — providing fresh, clean spring or filtered water is essential to maintain hydration, aid digestion, and support cellular functions.[ A happy cat eating freshly chopped vegetables][ Cat enjoying a fresh vegetable snack as part of holistic pet care][Explore more about holistic pet nutrition and supplements][Learn about natural remedies for aging pets][Read the latest research on pet wellness from reputable veterinary sources]The Path to Pet Wellness: Holistic Approaches for a Longer, Happier LifeUnderstanding Holistic Pet Wellness — Why It MattersPractical Strategies for Supporting Your Pet's Wellness1. Nutrition as a Foundation for HealthTips for feeding your pet holistically:2. The Role of Supplements and Natural RemediesKey points:3. Monitoring and Adjusting Based on Your Pet's FeedbackActionable tip:Expert Insights: The BEAM Approach to Pet WellnessApplying BEAM:Why Holistic Pet Care Works — Real-Life SuccessFinal Thoughts: Take Charge of Your Pet's Well-BeingReady to Deepen Your Knowledge?Frequently Asked QuestionsWhat is the BEAM approach in pet health?How can I incorporate holistic nutrition into my pet's diet?Are supplements necessary for aging pets?Can hydration impact my pet's health?Supporting your pet with holistic approaches can lead to a longer, healthier, and happier life together. Small, mindful steps today create a lasting impact for tomorrow.

Cat & Cloud Podcast The Evolution of Leadership: From Barista to Business Owner - Episode #437 Cat & Cloud Coffee www.catandcloud.com/ Summary In Episode #437, Chris and Jared explore the real shift that happens when you move from barista to business owner. What once felt like fast-paced camaraderie and clear wins on bar becomes a slower, more complex game of systems, sacrifice, and long-term responsibility. They talk through the hidden cost of leadership, the tension between collaboration and independence, and why owners often see a hundred problems before they see progress. The takeaway: leadership evolves, satisfaction changes, and the key is choosing agency—building momentum on purpose instead of drifting through the role. Chapters 00:00 “Is Someone Dead?”: Walking Into a Silent Roastery Meditation 06:00 Love and Hate with Chris Baca 14:00 From Barista to Boss 20:00 The Cost of Leadership, Herb Brooks and Miracle:The Boys of ‘80 26:00 Where do you find satisfaction? 31:00 Business owners often only see what needs to be done 41:00 Agency: Stop Drifting and Choose Your Next Season Cat & Cloud: Instagram www.instagram.com/catcloudcoffee/ Webstore www.catandcloud.com/ We LOVE our Wholesale Partners! Interested in serving our coffee at your business? Learn more about our Partner Program https://catandcloud.com/pages/wholesale Links – Miracle: The Boys of '80 | Official Trailer, Netflix 2026 Cat & Cloud Coffee was founded in 2016 by three friends who believe experiences and connections shape our lives. Former barista champions and lifelong coffee professionals, they envisioned a better way to do business and set out to create a values-driven organization that put culture first. Our mission is to inspire connection by creating memorable experiences. Whether it's with guests in our 4 retail locations in Santa Cruz, our team members, or our wholesale partners across the country, we strive to leave everyone better than we found them. The Cat & Cloud Podcast is a space for us to share our experiences and adventures in coffee and business in hopes of inspiring more people to create culture and values-driven organizations.

The Path to Pet Wellness: Holistic Approaches for a Longer, Happier Life." Grandpa Bill explores holistic strategies to enhance your pet's well-being, drawing insights from expert pet health advocate Grandpa Bill. It covers topics like nutrition, supplements, and the BEAM approach to pet health, providing practical tips for pet owners. Dr. Jeff Feinman's “BEAM” acronym — Behavior, Energy, Appetite, Mood — encapsulates a holistic view of pet health. Grandpa Bill's experience with his cats shows how focusing on these areas can extend their lifespan and improve quality of life.Balance: Ensure your pet's diet supports physical and emotional balanceEnergy: Promote activity and prevent lethargy through diet and environmental enrichmentAppetite: Monitor for changes; a healthy appetite indicates good healthMood: Observe behavioral signs; a cheerful pet is a healthy pet#PetWellness, #,#BEAMFramework, #PetNutrition, #HolisticPetCare,Grandpa Bill's own pets serve as a testament to holistic care's effectiveness. His cats, Brady and Brody, reached ages well beyond average thanks to thoughtful nutrition, supplements, and attentive observation. His proactive approach emphasizes that small, consistent actions can lead to significant health benefits.He also highlights the importance of hydration, giving his cats tourmaline spring water, and adapting diets based on ongoing assessments — key ingredients for a thriving pet.Supporting your pet's health holistically is a loving investment that pays off in vitality and longevity. Start by integrating fresh foods into their diet, observe their responses carefully, and consult experienced holistic veterinarians when needed. Remember, small daily choices—like offering healthy snacks and ensuring proper hydration—can make a big differenceJoin upcoming webinars and talks on pet wellness, such as Grandpa Bill's scheduled sessions, to learn more about natural approaches to caring for your furry friend.BEAM stands for Behavior, Energy, Appetite, and Mood — key factors to assess and support for overall pet wellness.Start with small amounts of fresh vegetables like cabbage or carrots, finely chopped or pulsed, and gradually observe how your pet responds.Supplements can support health, especially for older pets, but should always be used under veterinary guidance tailored to your animal's needs.Absolutely — providing fresh, clean spring or filtered water is essential to maintain hydration, aid digestion, and support cellular functions.[ A happy cat eating freshly chopped vegetables][ Cat enjoying a fresh vegetable snack as part of holistic pet care][Explore more about holistic pet nutrition and supplements][Learn about natural remedies for aging pets][Read the latest research on pet wellness from reputable veterinary sources]The Path to Pet Wellness: Holistic Approaches for a Longer, Happier LifeUnderstanding Holistic Pet Wellness — Why It MattersPractical Strategies for Supporting Your Pet's Wellness1. Nutrition as a Foundation for HealthTips for feeding your pet holistically:2. The Role of Supplements and Natural RemediesKey points:3. Monitoring and Adjusting Based on Your Pet's FeedbackActionable tip:Expert Insights: The BEAM Approach to Pet WellnessApplying BEAM:Why Holistic Pet Care Works — Real-Life SuccessFinal Thoughts: Take Charge of Your Pet's Well-BeingReady to Deepen Your Knowledge?Frequently Asked QuestionsWhat is the BEAM approach in pet health?How can I incorporate holistic nutrition into my pet's diet?Are supplements necessary for aging pets?Can hydration impact my pet's health?Supporting your pet with holistic approaches can lead to a longer, healthier, and happier life together. Small, mindful steps today create a lasting impact for tomorrow.

In this rollercoaster episode, Cat & Nat peel back the curtain on their wild postpartum journeys, complete with lingerie in the delivery room, mini Oreos for survival, and unbelievable hospital stories. You'll discover: how perfectionist control falls apart in the first six months, the shocking reality of sleep training and weight loss expectations, and the crazy things we did to feel in control, like wardrobe planning for after birth. We break down the unspoken chaos of new motherhood, the mental health lows no one talks about, and the importance of asking are you okay? but in a non creepy way before the dark thoughts take over.This isn't your typical “she's fine, she's tired” postpartum chat. It's a raw, hilarious look at the real struggles behind the Instagram perfect scenes, because if you think parenthood is just cuddles and cute photos, think again. The stakes? Missing out on your own sanity if you don't talk about it. Finding humor and hope among the chaos because you're not alone in the trenches.Perfect for expecting moms, new parents, or anyone who's ever wondered if they're just losing it, spoiler: you're not alone. Tune in if you want a life-saving dose of reality, a few belly laughs, and the reminder that sometimes, just surviving the day is an epic victory. Hosted on Acast. See acast.com/privacy for more information.

Next week kicks off the "Year of the Horse" in China. So, we will discuss the massive pre-holiday cash injection coming from China's central bank… and whether it’s a trap for foreign investors.Today's Stocks & Topics: Sprouts Farmers Market, Inc. (SFM), Risk On-Risk Off, Market Wrap, UnitedHealth Group Incorporated (UNH), The "Lunar New Year" Liquidity Pump, Backdoor Roth I-R-A, PEG Ratios, Caterpillar Inc. (CAT), Read Support and Enter Position?, Risk Off Enviroment.Our Sponsors:* Check out Quince: https://quince.com/INVESTAdvertising Inquiries: https://redcircle.com/brands

On this episode of Cattitude, host Michelle Fern dives into the fascinating world of cat influencers with Ashley, CEO of Pet Influencer Secrets and proud cat mom to Chip — the “world's most famous Manx cat” — and Biscuit, her adorable calico sidekick. Ever wondered what it really takes to turn your cat into a social media star? From storytelling and brand collaborations to behind-the-scenes realities (including picky cats and litter mishaps!), Ashley shares insider tips on how everyday cat parents can build authentic audiences — and even turn content into a business. They also tackle the rise of AI in pet content, how to avoid brand scams, and why emotional connection — not just cute photos — is the secret to success. If you've ever thought, “My cat could be famous,” this episode is your starting point.EPISODE NOTES: From Meow to Millions: Inside the World of Cat InfluencersBecome a supporter of this podcast: https://www.spreaker.com/podcast/cattitude-the-1-cat-podcast--6666768/support.

A supervisor leads a team of very needy CAT adjusters! Over the course of the year, the supervisor fields many questions as it comes up in their claims. Was there hail on X date? Was there lightning in the area? This hurricane is coming soon, where can I get news about it? Winter weather caused a slip and fall!! Where can I find information on wildfire perimeters and California evacuations? For help herding all these cats, we'll head to PLRB.org.   Notable Timestamps [ 00:00 ] - The episode introduces a scenario where a supervisor fields constant weather-related questions from cat adjusters, highlighting the need for a centralized, reliable source for hail, lightning, hurricanes, wildfires, and more. [ 02:15 ] - The team previews multiple scenarios—winter storms, hail, lightning, power outages, tornadoes, hurricanes, and wildfires—showing the breadth of searchable weather data available to support claim investigations. [ 03:16 ] - Using a winter slip-and-fall in Iowa City, Iowa, the report pulls verified storm data from the National Weather Service, including freezing rain reports and hourly observations to validate conditions on the date of loss. [ 07:42 ] - For hail damage in Illinois, radar-derived data and verified hail reports allow adjusters to map proximity, estimated hail size, and associated severe thunderstorm warnings tied to a specific date and address. [ 09:53 ] - Lightning reports provide daily probability percentages and satellite detection data, helping assess commercial equipment claims while noting limits in resolution and cloud-to-cloud versus cloud-to-ground distinctions. [ 12:25 ] - Power outage searches archive data every ten minutes via PowerOutage.us, identifying outage timing, affected customers, and likely storm causes—critical for business interruption investigations. [ 14:09 ] - A tornado case study of the Mayfield event demonstrates wind reports, damage points, and EF-scale path polygons, enabling precise analysis of storm track and intensity relative to a property. [ 17:31 ] - Wildfire tools include historical perimeters like the Garnett Fire, evacuation zones, thermal hotspots, smoke analysis from National Oceanic and Atmospheric Administration data, and hurricane spaghetti models—underscoring a single portal for comprehensive weather intelligence. [ 17:49 ] - Dylan summarized upcoming PLRB Weather/CATs developments. Your PLRB Resources Weather/CATS Hub - https://members.plrb.org/weather-cat/ Employees of member companies also have access to a searchable legal database, hundreds of hours of video trainings, building code materials, weather data, and even the ability to have your coverage questions answered by our team of attorneys (https://www.plrb.org/ask-plrb/) at no additional charge to you or your company. Subscribe to this Podcast Your Podcast App - Please subscribe and rate us on your favorite podcast app YouTube - Please like and subscribe at @plrb LinkedIN - Please follow at "Property and Liability Resource Bureau" Send us your Scenario! Please reach out to us at 630-509-8704 with your scenario! This could be your "adjuster story" sharing a situation from your claims experience, or a burning question you would like the team to answer. In any case, please omit any personal information as we will anonymize your story before we share. Just reach out to scenario@plrb.org.  Legal Information The views and opinions expressed in this resource are those of the individual speaker and not necessarily those of the Property & Liability Resource Bureau (PLRB), its membership, or any organization with which the presenter is employed or affiliated. The information, ideas, and opinions are presented as information only and not as legal advice or offers of representation. Individual policy language and state laws vary, and listeners should rely on guidance from their companies and counsel as appropriate. Music: "Piece of Future" by Keyframe_Audio. Pixabay. Pixabay License. Font: Metropolis by Chris Simpson. SIL OFL 1.1. Icons: FontAwesome (SIL OFL 1.1) and Noun Project (royalty-free licenses purchased via subscription). Sound Effects: Pixabay (Pixabay License) and Freesound.org (CC0).

Catéchèse du P. Mathieu - 2026-02-13 La grâce du baptême by Radio Maria France

We're entering February and with it comes a new month theme and we're doing "Female Rage". We've picked up this witchy horror novel and we've got thoughts about it!We also apologize the sound quality isn't the best this episode, we're not sure what happened to Cat's mic! We're hoping it's fixed by next episode!Thanks for listening!

Listen to the universe!/A cursed film on YouTube? Fan Art by Cabot Cove Balloon Friends I will be speaking at the Oregon Ghost Conference March 27-29 2026 For more info, tickets, and more: http://www.oregonghostconference.com/   Patreon (Get ad-free episodes, Patreon Discord Access, and more!) https://www.patreon.com/user?u=18482113 PayPal Donation Link https://tinyurl.com/mrxe36ph MERCH STORE!!! https://tinyurl.com/y8zam4o2 Amazon Wish List https://www.amazon.com/hz/wishlist/ls/28CIOGSFRUXAD?ref_=wl_share Dead Rabbit Radio Archive Episodes https://deadrabbitradio.blogspot.com/2025/07/ episode-archive.html https://archive.ph/UELip Dead Rabbit Radio Recommends Master List https://letterboxd.com/dead_rabbit/list/dead-rabbit-radio-recommends/ Links: EP 1546 - NDE: Near Deaf Experience (Slug episode) https://deadrabbitradio.libsyn.com/ep-1546-nde-near-deaf-experience EP 1093 - Figure 8 (Egypt Hot Air Balloon episode) https://deadrabbitradio.libsyn.com/ep-1093-figure-8 EP 1473 - Did Seth MacFarlane Sell His Soul To The Demon Roy Jay? https://deadrabbitradio.libsyn.com/ep-1473-did-seth-macfarlane-sell-his-soul-to-the-demon-roy-jay Jinn Episodes https://deadrabbitradio.blogspot.com/2025/05/jinn-episodes.html What's the one moment in your life you still can't explain… even though you've replayed it in your head a thousand times? (Gut Feeling Girl Overcome With Emotion Goes Home From School Father Dies story) https://www.reddit.com/r/AskReddit/comments/1p1ixik/comment/nps6m6h/ Archive https://archive.ph/ab9EZ How close have you ever been to death? Near death experiences or just getting lucky in a potentially dangerous situation? (Gut Instinct Car Accident story) https://www.reddit.com/r/AskReddit/comments/1qozbmt/comment/o269grw/ Archive https://archive.ph/wEjDV Aada Lintakem Movie | The movie "He Returned to Take Revenge" https://www.youtube.com/watch?v=qZ4Wfrvvhmc The scene of the Barhatiyah incantation from the movie "He Returned to Take Revenge" is not for the faint of heart. Don't forget to subscribe to the channel. https://www.youtube.com/watch?v=LwTBDkzd4Bc The Egyptian Film That Recorded a Real Curse Spell https://www.reddit.com/r/HighStrangeness/comments/1qgzuin/the_egyptian_film_that_recorded_a_real_curse_spell/ Archive https://archive.ph/CzOJX Ada le-Yantaqem https://m.imdb.com/title/tt3312876/ The Changeling (film) https://en.wikipedia.org/wiki/The_Changeling_(film) The Changeling https://www.imdb.com/title/tt0080516/?ref_=nm_knf_t_1 Fares Ashour https://www.youtube.com/@Faresashourofficial An Exposition On Asma Ul Barhatiyah https://www.scribd.com/document/331581893/An-Exposition-on-Asma-Ul-Barhatiyah He returned to take revenge https://www.reddit.com/r/Cinema_Egypt/comments/1pjmgve/%D8%B9%D8%A7%D8%AF_%D9%84%D9%8A%D9%86%D8%AA%D9%82%D9%85/ The scary spell that was cut from the movie (He Came Back for Revenge) https://tinyurl.com/yc745vhu Egyptian films documenting real curses https://www.reddit.com/r/horror/comments/1qgoqr7/the_egyptian_film_that_recorded_a_real_curse/?tl=zh-hans Egyptian cinema is bigger than jokes! https://thmanyah.com/post/1kj4r91fhx_1jhggnmybp He returned to take revenge (film) https://ar.wikipedia.org/wiki/%D8%B9%D8%A7%D8%AF_%D9%84%D9%8A%D9%86%D8%AA%D9%82%D9%85_%28%D9%81%D9%84%D9%85%29 In pictures and video - The disaster of black magic entering every home in Egypt through a movie - It wasn't a fictional scenario, but black magic spells https://eslamelbahrawy.blogspot.com/2018/12/blog-post_50.html The time machine https://tinyurl.com/2ka9b56r   ------------------------------------------------ Logo Art By Ash Black Opening Song: "Atlantis Attacks" Closing Song: "Bella Royale" Music By Simple Rabbitron 3000 created by Eerbud Thanks to Chris K, Founder Of The Golden Rabbit Brigade Dead Rabbit Archivist Some Weirdo On Twitter AKA Jack YouTube Champ: Stewart Meatball Reddit Champ: TheLast747 The Haunted Mic Arm provided by Chyme Chili Discord Mods: Mason Forever Fluffle: Cantillions, Samson, Gregory Gilbertson, Jenny the Cat http://www.DeadRabbit.com Email: DeadRabbitRadio@gmail.com Facebook: www.Facebook.com/DeadRabbitRadio TikTok: https://www.tiktok.com/@deadrabbitradio Dead Rabbit Radio Subreddit: https://www.reddit.com/r/DeadRabbitRadio/ Paranormal News Subreddit: https://www.reddit.com/r/ParanormalNews/ Mailing Address Jason Carpenter PO Box 1363 Hood River, OR 97031 Paranormal, Conspiracy, and True Crime news as it happens! Jason Carpenter breaks the stories they'll be talking about tomorrow, assuming the world doesn't end today. All Contents Of This Podcast Copyright Jason Carpenter 2018 - 2025  

Coucou everyone!A mystery grounded in fact, Cat tells the story of the mythically wealthy alchemist, polyglot, musician, scientist, philosopher, and artist - the Comte de Saint-Germain. A friend to Marie-Antoinette, Volatire, Casanova, Mozart, and several kings, he was rumored to be hundreds of years old. Kate also shares the history and meaning behind the king cake - laissez les bons temps rouler! Main topic sources: The Life and Times of an Immortal AlchemistComte de Saint-Germain | Mystic, Alchemist, Occultist | Britannica Count of St. Germain - Wikipedia Mini topic sources:King CakeVisit Lake Charles: King CakeKate's recommendation: The Piano Teacher Film (2001)Catherine's recommendation: ⁠⁠⁠Madame Bovary by Gustave FlaubertDon't forget to follow us on ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ & ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Tiktok⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ :)Cover art and logo by Kate WalkerMixed and edited by Catherine RoehreTheme song by LumehillThank you all - ciao!

Catéchèse du P. Mathieu - 2026-02-12 La nécessité du baptême by Radio Maria France

The loss of a pet can affect you more than losing a loved one, a new study shows. With one exception.

Send a textFollow along with Dr. Chastain and Ginger as they explain the:Definition of ponyingBenefits of ponying a horseTechniques to avoid risks of ponying horsesLink to show notes: BetterAnimalHandling.com

Host Dr. Davide Soldato and guests Dr. David Einstein and Dr. Ravi Madan discuss JCO article, "National Cancer Institute's Working Group on Biochemically Recurrent Prostate Cancer: Clinical Trial Design Considerations," underscoring the need for a consensus on clinical trial designs implementing novel endpoints in this population, the importance of PSA doubling time as a prognostic factor and with an emphasis on treatment de-escalation to limit toxicity and improve patient outcomes. TRANSCRIPT The disclosures for guests on this podcast can be found in the show notes. Davide Soldato: Hello and welcome to JCO After Hours, the podcast where we sit down with authors from some of the latest articles published in the Journal of Clinical Oncology. I am your host, Dr. Davide Soldato, medical oncologist at Ospedale San Martino in Genoa, Italy. Today, we are joined by JCO authors Dr. David Einstein and Dr. Ravi Madan. Dr. Einstein is a medical oncologist specializing in genitourinary malignancy working at Beth Israel Deaconess Medical Center, part of the DFCI Cancer Center, and an assistant professor at Harvard Medical School. Dr. Madan is a senior clinician at the National Cancer Institute (NCI), where he focuses on conducting clinical research in prostate cancer, particularly in the field of immunotherapy. Today, we will be discussing the article titled, "National Cancer Institute's Working Group on Biochemically Recurrent Prostate Cancer: Clinical Trial Design Considerations." So, thank you for speaking with us, Dr. Einstein and Dr. Madan. David Einstein: Thanks for having us. This is a great pleasure. Ravi Madan: Appreciate being here. Davide Soldato: So, I just want to start from a very wide angle. And the main question is why did you feel that there was the need to convey a consensus and a working group to talk about this specific topic: biochemically recurrent prostate cancer? What has been the change in current clinical practice and in the trial design that we are seeing nowadays? And so, why was it necessary to convey such a consensus and provide considerations on novel clinical trials? David Einstein: Yeah, so I think it's very interesting, this disease state of biochemically recurrent prostate cancer. It's very different from other disease states in prostate cancer, and we felt that there was a real need to define those differences in clinical trials. Years ago, metastatic castration-resistant prostate cancer was the primary disease state that was explored, and over time, a lot of things shifted earlier to metastatic disease defined on a CAT scan and bone scan to an earlier disease state of metastatic castration-sensitive prostate cancer. And the clinical trial principles from late-stage could be applied to MCSPC as well. However, BCR is very different because the patients are very different. And for those reasons, there are unique considerations, especially in terms of toxicity and treatment intensity, that should be applied to biochemically recurrent prostate cancer as opposed to just using the principles that are used in other disease states. And for that reason, we thought it was very important to delineate some of these considerations in this paper with a group of experts. Davide Soldato: Thanks so much. So, one of the main changes that have been applied in recent years in clinical practice when looking at biochemically recurrent prostate cancer is the use of molecular imaging and particularly of PSMA PET. So, first of all, just a quick question: was the topic of the consensus related on which threshold of PSA to use to order a PET scan to evaluate this kind of patient? David Einstein: Yeah, thanks for that question. It's a super important one. The brief answer is that no, we did not address questions about exactly when clinicians would decide to order scans. We were more concerned with the results of those scans in how you define different disease states. But I think as a broader question, I think a lot of folks feel that finding things on a scan equates that with what we used to find on conventional scans. And fundamentally, we actually sought to redefine that disease space as something that's not equivalent to metastatic disease, and rather coined the term "PSMA-positive BCR" to indicate that traditional BCR prognostic criteria and factors still apply, and that these patients have a distinct natural history from those with more advanced metastatic disease. Ravi Madan: And if I may just add that the National Cancer Institute is running a trial where we're prospectively monitoring PSMA-positive BCR patients. And that data is clearly showing that, much like what we knew about BCR a decade ago, PSMA findings in BCR patients do not change the fact that overall, BCR is an indolent disease state. And the findings, which are usually comprised of five- to seven-millimeter lymph nodes, do not endanger patients or require immediate therapy. And so, while PSMA is a tool that we can be using in this disease state, it doesn't really change the principal approach to how we should manage these patients. And as Dr. Einstein alluded to, there is a drive to create a false equivalency between PSMA-positive BCR and metastatic castration-sensitive prostate cancer, but that is not supported by the data we're accumulating or any of the clinical data as it exists. Davide Soldato: One thing that it's very important and you mentioned in your answer to my question was actually the role of PET scan and conventional imaging, so CAT scan and bone scan that we have used for years to stage patients with metastatic prostate cancer. And you mentioned that there is a distinction among patients who have a positive PET scan and a BCR, and patients who have a positive conventional imaging. And yet, we know that sometimes the findings of the PET scan are not always so clear to interpret. So, I just wanted to understand if the consensus reached an agreement as to when to use conventional imaging to potentially resolve some findings that we have on PET scan among thess patients with BCR? David Einstein: Yeah, I think there's a number of questions actually buried within that question. One of which is: does PSMA PET result in false positives? And the answer has definitely been yes. There's a known issue with false-positive rib lesions. And so, first and foremost, we need to be very careful in calling what truly is suspicious disease and what might actually not be cancer or might be something that is totally separate. So I think that's the first part of the answer to that question. The second is to what extent do we need to use paired PET and conventional imaging to define this disease state? In other words, do you have to have positive findings on one and negative findings on the other in order to enter this definition? The challenge there, as we discussed, is that logistically, oftentimes it's hard to get patients to do multiple sets of scans to actually create that definition. Sometimes it's difficult to get insurers to pay for such scans. And finally, it's hard to sometimes blind radiologists to the results of one scan in reading the other. So, we did have some deliberations about to what extent you could use some of the CAT scan portion of a PSMA PET in order to at least partially define that. We also talked about using bone scans to confirm any bone findings seen on PET. But I think another important part of this is not just the baseline imaging, but also what's going to be done serially on a study in order to define responses and progression. And that's sort of a whole separate conversation about to what extent you can interpret changes in serial PET. Ravi Madan: And just to pick up on the key factor here, I think that the PSMA PET in BCR is pretty good at defining lymph node disease, and that's actually predominantly 80 to 90 percent of the disease seen on these findings. It might be pretty good at also defining other soft tissue findings. The real issues come to bone findings. And one thing the group did not feel was appropriate was to just define only PSMA-positive bone findings confirmed on a CT bone window. There's not really great data on that, but the working group felt that, when in the rare situation, because it is relatively rare, a PSMA-positive finding is in a bone, a bone scan should be done. And it's worth noting that Phu Tran, who is a co-author and a co-leader of this working group, his group has already defined that underlying genomics of conventionally based lesions, such as bone scan, are more aggressive than findings on next-gen imaging, such as PSMA. So, there is also a genomic underlying rationale for defining the difference between what is seen on a PET scan in a bone and what is seen on a bone scan. Davide Soldato: Coming back to this issue of PET PSMA sometimes identifying very small lesions where we don't see any kind of correlates on conventional imaging or where we see only very little alteration on the bone scan or in the CT scan, was there any role that was imagined, for example, for MRI to distinguish this type of findings on the PET scan? Ravi Madan: So, I think that, again, what can be identified on a PSMA frequently cannot be seen on conventional imaging. We didn't feel that it was a requirement to get an MRI or a CT to necessarily confirm the PSMA findings. I think that generally, we have to realize that in this disease state, that questionable lesions are going to be seen on any imaging, including PSMA. We've actually probably put way too much faith in PSMA findings thus far, as Dr. Einstein alluded to with some of the false positives we're seeing. So, I think that these false positives are going to have to be baked into trials. And in terms of clinical practice, it highlights the need to again, not overreact to everything we see and not necessarily need to biopsy everything and put patients' health in jeopardy to delineate a disease that's indolent anyway. Davide Soldato: Thanks so much. That was very clear. So, basically, the main driver was really also the data showing that if we have a BCR, so a patient with a biochemically recurrent disease that is positive on the conventional imaging, this is usually associated with a different aggressiveness of the disease. But coming back to a comment that you made before, Dr. Madan, you said that even if we talk about PSMA-positive BCR, we are still talking about BCR and the same criteria should apply. So, what we have used for years in this space to actually try to stratify the prognosis of patients is the PSA doubling time, so how quickly the PSA rises over time. So, coming back to that comment, was the consensus on the PSA doubling time basically retained as what we were using before, so defining patients with a doubling time less than 12 months, 10 months, 9 months, as patients with a higher risk of progressing in terms of developing metastatic disease? Ravi Madan: Yes, so that's a very important point. And the working group defined high-risk BCR as a PSA doubling time less than six months. And this really comes from Johns Hopkins historical data, which shows that if your doubling time is three months or less, there's about a 67 percent chance of metastasis at five years. If it's between three and six months, it's 50 percent. And if it's over six months, if it's between six and nine months, it's roughly only 27 percent. There are trials that are accruing with eligibility criteria that they may describe as high-risk that are beyond six months, but the data as really it's been defined in the literature highlights that truly high-risk BCR is less than six months. And the working group had a consensus on that opinion, and that was our recommendation. David Einstein: And I think an important follow-on to that is that's regardless of PET findings, right? And so, we present a couple of case studies of patients with positive PET findings who have a long doubling time, in whom the disease is in fact indolent, as you would have expected from a traditional BCR prognostic standpoint. Obviously, there are patients in whom they have fast doubling times, and even if they do not have PET findings, that doesn't make them not high-risk. Ravi Madan: And just to follow up that point, I will let you know a little bit of a free preview that my colleague Melissa Abel from the NCI will be presenting PSMA findings in the context of PSA doubling time at ASCO GU if that data is accepted. Davide Soldato: Looking forward for those data because I think that they're going to clarify a lot of the findings that we have in this specific population. And coming back to one of the points that we made before, so PET PSMA has a very high ability to discriminate also a very low burden of disease, which we currently refer to as oligometastatic biochemically recurrent prostate cancer, which is not entirely defined as an entity. But what we are seeing both in some clinical trials, which use mainly conventional imaging, but also what we're starting to see in clinical practice, is that frequently we use the metastasis-directed therapy to treat these patients. So, just a little bit of a comment on the use of this type of strategy in clinical practice and if the panel thought of including this as, for example, a stratification criteria or mandated in the design of novel clinical trials in the field of BCR? David Einstein: Yeah, I think that's an incredibly important point. You know, fundamentally, there's a lot of heterogeneity in practice where some folks are using local salvage approaches, some are using systemic therapies, in some cases surveillance may be reasonable, or some combination of these different strategies. We certainly have phase two data from multiple trials suggesting that met-directed therapy may help buy patients time off of treatment until subsequent treatments are started. And that in and of itself may be an important goal that we can come back to in discussing novel endpoints. I think what our panel acknowledged was that, in some sense, the clinical practice has gotten even farther ahead than where the data are, and this is being offered pretty routinely to patients in practice. And so, what became clear was that we, in developing clinical trials, cannot forbid investigators from doing something that would be within their usual standard of care, even if it might not be supported by the most robust data. But at minimum, it definitely should be used as a stratification factor, or in some trial designs, you can do met-directed therapy after a primary endpoint is assessed. And that offers a compromise between testing, say, the effect of a systemic therapy but also not excluding patients and investigators from doing what they would have done had they not been on a study. Ravi Madan: And I would just like to follow up your phrasing in the question of "oligometastatic prostate cancer." We have a figure in the paper and it highlights the fact that, unfortunately, that term in prostate cancer is imaging agnostic. And we've already discussed in this podcast, as well as in the paper, that imaging used to define a metastatic lesion, whether it's PSMA or conventional imaging, carries with it a different clinical weight and a different prognosis. So, we feel in the working group, that the correct term for this disease state of PSMA-positive BCR is just that: PSMA-positive BCR. We also have to realize that when we talk about oligometastatic disease, while it's imaging agnostic, it seems to be numerically based, whether it's five or three or 10 depending on the trial. But PSMA-positive BCR does not have a limit in terms of the number of lesions. And so again, we just feel that there is an important need to delineate what we're seeing in this disease state, which again is PSMA-positive BCR, and that should be differentiated frankly from oligometastatic disease defined on other imaging platforms. David Einstein: Right, and that also makes clear that patients can have polyfocal disease on PET that still is not what we would consider metastatic, but goes beyond the traditional definition of oligometastatic. So, in other words, just because someone has PET-detected disease only, that does not automatically equate with oligometastatic. Davide Soldato: Thanks so much. So, you were speaking a little bit, Dr. Einstein, about the different types of treatment that we can propose or not propose to this patient because you mentioned, for example, that in clinical practice MDT, so metastasis-directed therapy, is becoming more and more used. For these patients, we can potentially use systemic treatments, which include androgen deprivation therapy, which can be given continuously or in an intermittent fashion. And recently, we can also use novel systemic therapies, for example, enzalutamide, to treat this type of patient. So, given that the point of the consensus was really to provide consideration for novel clinical trials in this space, what was the opinion on the panel regarding the control arm? So, if we're looking at a novel therapy in the BCR space, does the control arm need to include a therapy or not? And if so, which therapy? David Einstein: Yeah, this is a super important question and one that's subject to a lot of discussion, especially in light of recent data from EMBARK. What we came to a consensus around was the fact that neither MDT nor systemic therapy should be required as a control arm on BCR trials. And we can talk about a number of reasons for that. There's also the pragmatics of what investigators might actually accrue patients to and what they would consider their standard of care, and that's important to factor in, too. I think that one of the major goals of our working group was outlining what kinds of trials we would like to see in the future and where the limitations of the current data stand. For example, EMBARK proposes a strategy of a single treatment discontinuation and resumption at a predefined threshold indefinitely. That's probably not how most people are practicing. Most folks are probably using some version of intermittent therapy as they would have before this trial, but we actually don't have any data supporting that. Moreover, we don't have data comparing different intermittent strategies to one another. We don't know what the right thresholds are, we don't know how much time we buy patients off treatment, and we don't know to what extent MDT modifies that. And so, those are all really important questions to be asking in future versions of these trials. I'd say my second point would be that a lot of drug development is happening with novel therapies that are not hormonal, trying to bring them into this space. And when you think about trying to compare one of those types of therapies to a hormonal therapy on short-term endpoints, the hormonal therapy is always going to win. Hormonal therapy is almost universally effective, it will bring down PSAs, and it will prolong, quote-unquote, "progression." The downside of that is that hormonal therapy doesn't actually modify the disease, it suppresses it, and it tends to have fairly transient effects once you remove it. And so, part of our goal was in trying to figure out some novel endpoints that would allow these novel types of therapies to be examined head-to-head against a more traditional type of hormonal therapy and have some measurement of some of the more long-term impacts. Davide Soldato: So, jumping right into the endpoints, because this is a very relevant and I think very well-constructed part of the paper that you published. Because in the past we have used some of these endpoints, for example, metastasis-free survival, as potentially a proxy for long-term outcomes. But is this the right endpoint to be using right now, especially considering that frequently this outcome is measured using conventional imaging, but we are including in these trials patients who are actually negative on conventional imaging but have a positive PSMA when they enter this type of trial? David Einstein: Yeah, there's a number of challenges with those types of endpoints. One of which is, as you say, we're changing the goalposts a little bit on how we're calling progression. We still don't exactly understand what progression on PET means, and so that's something that is challenging. That said, we're also cognizant of the fact that many times investigators are likely to get PET scans in the setting of rising PSA, and that's going to affect any endpoint that relies purely on conventional imaging. So, there's some tension there between these two different sets of goalposts. One thing that we emphasize is that not only are there some challenges in defining those, but also there're challenges in what matters to a patient. So, if a progression event occurs in the form of a single lesion on a PET scan or even a conventional image, that might be relevant for a clinical trial but might be less relevant for a patient. In other words, that's something that, in the real world, an investigator might use serial rounds of metastasis-directed therapy or intermittent therapy to treat in a way that doesn't have any clinical consequences for the patient necessarily. In other words, they're asymptomatic, it's not the equivalent of a metastatic castration-resistant disease progressing. And so, we also need to be cognizant of the fact that if we choose a single endpoint like PFS, that there's going to be many different versions of progression, some of which probably matter clinically more than others, and some of which are more salvageable by local therapies than others. Ravi Madan: So I think the working group really thoughtfully looked at the different options and underscored perhaps strengths and weaknesses, and I think that's presented as you mentioned in the paper. But I think it's also going to depend on the modality, the approach of the therapeutic intervention. In some cases if it's hormone-based, then maybe PSA is providing some early metrics, maybe metastasis-free survival is more relevant in a continuous therapy, but intermittent therapies might have a different approach. There's emerging immunotherapy strategies, radiopharmaceutical strategies, they might have some more novel strategies as well. I think we have to be open-minded here, but we also have to be very clear: we do not know what progression is on a PSMA scan. Just new lesions may not carry the clinical significance that we think, and we may not know what threshold that ultimately becomes clinically relevant is. So, I do think that there was some caution issued by the working group about using PSMA as an endpoint because we still do not have the data to understand what that modality is telling us. Again, I'm optimistic that the National Cancer Institute's prospective data set that we've been collecting, which has over 130 patients now, will provide some insights in the months and years ahead. Davide Soldato: So, just to ask the question very abruptly, what would you feel like the best endpoint for this type of trials is? I understand that is a little bit related to the type of treatments that we're going to use, whether it's intermittent, whether it's continuous, but do we have something that can encapsulate all of the discussion that we have up until this point? David Einstein: Yeah, so that's a perfect segue to the idea of novel endpoints, which we feel are very important to develop in these novel disease spaces. So, one thing that we discussed was an endpoint called treatment-free survival, which conceptually you can think of as exactly what it sounds like, but statistically you actually have to do some work to get there. And so essentially, you imagine a series of Kaplan-Meier curves overlaid: one about overall survival, one time to next therapy, one time on initial therapy. You can actually then take the area under those curves or between those curves and essentially sum it up using restricted mean survival time analysis. And that can give you a guide about the longitudinal experience of a patient: time spent on treatment versus off treatment; time spent with toxicity versus without toxicity. And importantly, each one of those time-to-event metrics can be adjusted depending on exactly what the protocol is and what is allowed or not allowed and what's prespecified as far as initiation of subsequent therapies. So, we felt that this was a really important endpoint to develop in this disease space because it can really capture that longitudinal aspect. It can really reward treatments that are effective in getting durable responses and getting patients off of therapy, because unfortunately, PFS-based endpoints generally reward more or longer systemic therapy versus shorter or no systemic therapy, and that's sort of an artificial bias in the way those endpoints are constructed. So, I think that there are challenges of course in implementing any new endpoint, and some of the things that are really critical are collecting data about toxicity and about subsequent therapies beyond what a typical trial might collect. But I think in this kind of disease space, that longitudinal aspect is critical because these are really patients who are going to be going through multiple rounds of therapy, going to be going on and off treatments, they're going to be using combinations of local and systemic therapies. And so, any one single endpoint is going to be limited, but I think that really highlights the limitations of using PFS-based endpoints in this space. Ravi Madan: I also think that in the concept of treatment-free survival lies one of the more powerful and, honestly, I was surprised by this, that it was so universally accepted, recommendations from the committee. And that was that the general approach to trials in this space should be a de-escalation of the EMBARK strategy as it's laid out with relatively continuous therapy with one pause. And so, I think again, buried in all of this highlights the need for novel endpoints like treatment-free survival. We get to the fact that these are patients who are not at near-term clinical risk from symptoms of their disease, so de-escalating therapies does not put them at risk. And if you look at, for example, lower-volume metastatic castration-sensitive prostate cancer, it's become realized that we need to de-escalate, and there are now trials being done to look at that. Historically, we know that BCR is an indolent disease process for the vast majority of patients who are not at near-term risk from clinical deterioration. So, therefore, we shouldn't wait a decade into abundant BCR trials to de-escalate. The de-escalation strategy should be from the outset. And that was something the committee really actually universally agreed on. David Einstein: And that de-escalation can really take multiple forms. That could be different strategies for intermittent therapy, different start-stop strategies. It could also mean actually intensifying in the short-term with the goal long-term de-intensification, kind of analogous to kidney cancer where we might use dual checkpoint inhibitors up front with some higher upfront toxicity but with the hope of actually long-term benefit and actually being able to come off treatment and stay in remission. Those kinds of trade-offs are the types of things that are challenging to talk about. There's not a one-size-fits-all answer for every patient. And so, that's why some of these endpoints like treatment-free survival would be really helpful in actually quantifying those trade-offs and allowing each patient to make decisions that are concordant with their own wishes. Davide Soldato: Thanks so much. That was very clear, especially on the part of de-escalation, because, as you were mentioning, I think that we are globally talking about a situation, a clinical situation, where the prognosis can be very good and patients can stay off treatment for a very long period of time without compromising long-term outcomes. And I think that well-constructed de-escalation trials, as you were mentioning and as the consensus endorsed, are really needed in this space also to limit toxicity. This brings us to the end of this episode. So, I would like to thank again Dr. Einstein and Dr. Madan for joining us today. David Einstein: We really appreciate the time and the thought, and I think that even starting these types of discussions is critical. Even just recognizing that this is a unique space is the beginning of the conversation. Ravi Madan: Yeah, and I want to thank JCO for giving us this forum and the opportunity to publish these results and all the expert prostate cancer investigators who were part of this committee. We produced some good thoughts for the future. Davide Soldato: We appreciate you sharing more on your JCO article titled, "National Cancer Institute's Working Group on Biochemically Recurrent Prostate Cancer: Clinical Trial Design Considerations." If you enjoy our show, please leave us a rating and review and be sure to come back for another episode. You can find all ASCO shows at asco.org/podcasts. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinion of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.  

Silver, Gold and Crypto (oh my) Hang on – Wild ride here Superbowl, Olympics- Wait until you hear about the CAPex spending! Shakeup in Dietville PLUS we are now on Spotify and Amazon Music/Podcasts! Click HERE for Show Notes and Links DHUnplugged is now streaming live - with listener chat. Click on link on the right sidebar. Love the Show? Then how about a Donation? Follow John C. Dvorak on Twitter Follow Andrew Horowitz on Twitter Interactive Brokers  Warm-Up - Silver, Gold and Crypto (oh my) - Need a stock for CTP - Hang on - Wild ride here - Superbowl, Olympics- Wait until you hear about the CAPex spending! - Shakeup in Dietville Markets - Massive moved during the week - - Bitcoin clipped $60k before rebounding - DJIA tops 50,000 for the first time - Wait until you hear about the CAPex spending! - CAT == 1,100 points on the DJIA in 2026 Superbowl and Superbowl ads - Game review - Any ad stick out? - $10M per ad this year - Half Time with Bad Bunny? - Anthropic busting on OpenAi Last Week! - Massive moved - quick calc showed that about $1T was wiped from market caps in the sell-off, particularly in tech names. - HOWEVER - Friday alone is estimated to have added $1.5T to market cap AI Ripping Through - Plenty of names getting cooked over AI announcements - First it was the software companies - Now there are names in legal and finance that got clocked - Today - Altruist.ai can do tax planning and that hurt companies in financial space Earnings Season Update - Reporting so far: 59% of S&P 500 companies have reported Q4 2025 results. - Beat rate: 76% have topped EPS estimates (vs. 5-yr average: 78% (slightly lower) vs. 10-yr average: 76% (in line) - Magnitude of beats (aggregate): earnings are 7.6% above estimates vs. 5-yr average: 7.7% (about the same) vs. 10-yr average: 7.0% (a bit better) - Nothing great,  like Goldilocks Earnings Highlights - Palantir (PLTR): Reported strong Q4 results early in the week , beating estimates with revenue ~$1.41B (vs. ~$1.33B expected) and EPS $0.25 (vs. $0.23). Guidance for 2026 was upbeat (~61% revenue growth). Shares rallied sharply initially (~7–11% post-earnings), but gave back some gains amid broader tech volatility (e.g., down ~11–22% in parts of the week from peaks). - AMD: Reported mid-week, beating EPS (~$1.53 vs. lower expectations) with solid data center growth (~39%). However, Q1 guidance disappointed relative to high expectations in the AI chip space. Shares sank dramatically — down ~15–17% the next day, with some reports noting up to 20%+ drops at points, contributing to broader chip sector pressure. - Alphabet (GOOGL/GOOG): Reported beating on revenue (~$113.8B) and EPS (~$2.82), with strong core performance. But capex guidance for 2026 ($175–$185B, roughly double prior levels) sparked AI spending worries. Shares dipped post-earnings (down ~0.5–5% initially, flat to lower the next day, with some volatility pulling it below key moving averages). - Amazon (AMZN): Reported after hours on February 5, with mixed results — EPS ~$1.95 (narrow miss vs. ~$1.97 expected), but solid overall. The big negative was a surprise $200B capex forecast for 2026 (well above expectations), tied to AI/cloud buildout. Shares plunged sharply — down ~7–10% in after-hours/extended trading, with Friday moves around -5–8% in some sessions. Recent Tech CAPEX announcements - Amazon (AMZN) — Guided to approximately $200 billion in capex for 2026 (a massive jump from ~$125–131 billion in 2025, with ~80% likely AI-related per analyst commentary). This was the largest single-company figure and a major surprise, contributing heavily to the week's "wild" reactions. - Alphabet (GOOGL/GOOG) — Guided to $175–185 billion in capex for 2026 (roughly double the $91 billion spent in 2025, far above analyst expectations of ~$115–119 billion). Emphasis was on AI compute capacity, servers, data centers, and networking to meet demand for Gemini and cloud services. - Meta Platforms (META) — Guidance from late January (but heavily discussed last week): $115–135 billion for 2026 (up significantly from ~$70–72 billion in 2025, potentially an ~87% increase). - Microsoft (MSFT) — No new full explicit 2026 guidance in early February (fiscal year runs July–June), but recent quarterly run-rate and analyst projections put it around $97–145 billion (with some sources citing ~$105 billion or higher based on Q2 spending trends and signals of continued growth from prior levels of ~$88 billion in FY2025). ------!!!!Combined 2026 capex projected at $635–665 billion (low/high ends) or up to $650–700 billion in some reports — a ~60–74% increase from their collective ~$381 billion in 2025. Market Reaction from all of this.... - Markets were a bit spooked on the Anthropic announcement earlier in the week - software sold off and set a sour mood - Microsoft dumped pretty hard as the amount of spend was higher than anticipated, especially with some slower growth in Azure. - Amazon took a beating on the increased spend they anticipate *(extra by $50B) - BUT: Friday markets rallied as there was realization that the $200B spend by Amazon would seep into the economy and fuel infrastructure spending along with chips, tech etc. Other Earnings of Interest -  Reddit reported fourth-quarter earnings on Thursday in which the social media company beat on the top and bottom lines. - The company said it expects first-quarter sales to come in the range of $595 million to $605 million, which is higher than Wall Street expectations of $577 million. - Reddit also announced a $1 billion share repurchase program. - Reddit gets about $250 million a year from OpenAi and Google to have your data for training their LLMs While we are on the subject - Friday, DJIA hit 50,000 - first time ever! - Up 1,200 point of which approx 350 was from caterpillar and 280 was from Goldman Sachs Hats off to WalMart - Walmart Inc. shares pushed its market capitalization past $1 trillion on Tuesday for the first time ever| - Big transformation over the pst year - Walmart has maintained its appeal to households looking for value, its online offerings are drawing new, wealthier shoppers seeking convenience. Google Bond Offering - Issuing several tranches of bonds, denominated in Stirling - one as long as 100 years - Would you buy that? - The Google parent is set to raise $20 billion from a US dollar bond offering on Monday — more than the $15 billion initially expected — and is also pitching investors on what would be its first ever offerings in Switzerland and the UK. - The latter would include a rare sale of 100-year bonds, the first time a tech company has tried such an offering since the dotcom frenzy of the late 1990s Fat Profits in Dietville - Really interesting sequence of events happening... - Hims launches compounded pill at prices as low as $49 per month - Analysts cite questions on efficacy, legality of pill - Hims' move shifts focus from Novo's strong Wegovy pill launch - Broader obesity market whipsawed as pricing pressure rises THEN.. - Hims and Hers Health shares dive 14% after hours on Friday (Down 25% on Monday) - FDA cites concerns over quality, safety, federal law - The U.S. Food and Drug Administration said on Friday it would take action against telehealth provider Hims & Hers, for its $49 weight-loss pill, including restricting access to the drug's ingredients and referring the company to the Department of Justice for potential violations of federal law. AND.... - Eli Lilly last Wednesday posted fourth-quarter earnings and revenue and 2026 guidance that blew past estimates, as demand for its blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro soars. - The pharmaceutical giant anticipates its 2026 revenue will come in between $80 billion and $83 billion. Analysts expected revenue of $77.62 billion, according to LSEG. - Meanwhile, NOVO had a really bad outlook that took the shares down 13% after the report. Japan Markets Soar - Japanese stocks jumped to a record high Monday, leading gains in the region after Prime Minister Sanae Takaichi won a landmark election victory. - The ruling Liberal Democratic Party captured a two-thirds supermajority in the 465-seat lower house, public broadcaster NHK reported. - Japan's Nikkei 225 jumped past 57,000 for the first time before paring gains to close 3.9% higher at 56,363.94, while the Topix also notched a record high, closing at 3,783.94, up 2.3%. Employment Report? - Government shutdown is forcing them to postpone again (Which is dumb) - Number due this Wednesday - Maybe because of this:U.S. employers announced 108,435 layoffs for the month, up 118% from the same period a year ago and 205% from December 2025. The total marked the highest for any January since 2009. - At the same time, companies announced just 5,306 new hires, also the lowest January since 2009, which is when Challenger, Gray & Christmas began tracking such data. - Also, job openings fell sharply in December to 6.54 million, to their lowest since September 2020. - Available jobs are down by more than 900,000 just since October. - NO! Ai and advancements in tech have noting to do with this! NO NO NO M&A - Texas Instruments Inc. has reached an agreement to buy Silicon Laboratories Inc. for about $7.5 billion, deepening its exposure to several markets for chips. - Silicon Labs investors will receive $231 in cash for each share of the company's common stock and the transaction is expected to close in the first half of 2027. - The transaction still needs to win approval by investors in Silicon Labs and shares of Silicon Labs surged by 51% to $206.48 after the announcement. Inflation - This helps - PepsiCo (PEP.O), opens new tab will cut prices on core brands such as Lay's and Doritos by up to 15% following a consumer backlash against several previous price hikes, the snacks and beverage maker said on Tuesday after it topped fourth-quarter results. Miran - Moving - Federal Reserve Governor Stephen Miran is leaving his post as chair of the Council of Economic Advisers, CNBC has confirmed. - He joined the CEA in January 2025, but had been on leave from that post since last September when he filled the unexpired term of former Fed Governor Adriana Kugler.- He reamins on Fed board No Biggie???? - There are some astonishing cased being reported of Bad AI in the operating room - JNJ's TruDi Navigation System - Since AI was added to the device, the FDA has received unconfirmed reports of at least 100 malfunctions and adverse events. - At least 10 people were injured between late 2021 and November 2025, according to the reports. Most allegedly involved errors in which the TruDi Navigation System misinformed surgeons about the location of their instruments while they were using them inside patients' heads during operations. - Cerebrospinal fluid reportedly leaked from one patient's nose. In another reported case, a surgeon mistakenly punctured the base of a patient's skull. In two other cases, patients each allegedly suffered strokes after a major artery was accidentally injured. Cuba - The main airport has putt out a bulletin that they are out of Jet Fuel - Blackouts and lack of other fuels are creating big problems - No airlines have stopped running at this point, but many will as they cannot refuel - This is a bigger problem for cargo planes (supplies) that may not be able to risk flying to Cuba as they will not be able to get out. Love the Show? Then how about a Donation? ANNOUNCING THE WINNER OF THE THE CLOSEST TO THE PIN CUP 2025 Winners will be getting great stuff like the new "OFFICIAL" DHUnplugged Shirt!     FED AND CRYPTO LIMERICKS   See this week's stock picks HERE Follow John C. Dvorak on Twitter Follow Andrew Horowitz on Twitter

Rima Jalba shares the good of the Cinnamon Trust, the UK national charity for older people, the terminally ill and their pets. The mission is as simple as it is clear: they provide hands-on assistance to pet owners across the country when any aspect of the day-to-day care of their pets poses a problem; as well as the provision of lifelong care for pets who outlive their owners. A life-long animal lover herself, Rima shares everything from her first pet as a child to how she made a life change, choosing to work for connection rather than just a paycheck. And that's exactly what brought her to the Cinnamon Trust's (doggie) door. For the animal lovers out there (just like us) and for anyone looking for inspiration on how to engage within your own community, this good one is for you. ___________________________ Steve's third book in his cozy mystery series, THE DOG WALKING DETECTIVES is finally here: SEASON'S SLAYINGS! Get your copy on Amazon: https://bit.ly/3WYTPiR or Barnes & Noble: https://bit.ly/4hOjILR Grab the first two: Book 1: DROWN TOWN Amazon: https://amzn.to/478W8mp Barnes & Noble: https://bit.ly/3Mv7cCk & Book 2: MURDER UNMASKED Amazon: https://shorturl.at/fDR47 Barnes & Noble: https://shorturl.at/3ccTy

The hilarious actor Vella Lovell is a put-upon director of an animal control precinct in the sitcom Animal Control, a role that involves much more animal contact than one would expect for an office job. Turns out Vella, who also played the neighbor Heather on Crazy Ex-Girlfriend, has a natural knack for helping animals calm down. This was evident in her long process of introducing a new kitten, XX, to her household, which already included a veteran resident cat, YY. Sleepyheads, the process took weeks of gentle, gradual exposure under highly controlled conditions, and we're pleased to report that it was a complete success. XX and YY are, today, best buddies. We think you'll be fast asleep before you ever get to that happy friendship moment but maybe you'll sleep a little better knowing that it turned out so well.Catch Season 4 of Animal Control on hulu and the previous three seasons on Netflix.Hey Sleepy Heads, is there anyone whose voice you'd like to drift off to, or do you have suggestions on things we could do to aid your slumber?Email us at: sleepwithcelebs@maximumfun.org.Follow the Show on:Instagram @sleepwcelebsBluesky @sleepwithcelebsTikTok @SleepWithCelebsJohn is on Bluesky @JohnMoeJohn's acclaimed, best-selling memoir, The Hilarious World of Depression, is now available in paperback._________________________________________________________________________Join | Maximum FunIf you like one or more shows on MaxFun, and you value independent artists being able to do their thing, you're the perfect person to become a MaxFun monthly member.

Catéchèse du P. Mathieu - 2026-02-11 La célébration du baptême by Radio Maria France

In today's episode, Amanda drinks some Zevia cream soda and root beer with writer, director, and producer Clara Altimas. Clara is a writer, director, and producer originally from Montreal, now based between Toronto and Los Angeles. She serves as showrunner, executive producer, and director on Crave's The Office Movers, created by Jay and Trey Richards, and is now working on season 3 of the series. She was previously a writer, producer, and director on CBC's Strays and Kim's Convenience. In addition to her television work, Clara has written and directed numerous short films, and is currently in development on her first feature film. She has also taken part in several major industry development programs, including the Canadian Film Centre's Writer's Lab and the Reykjavik International Film Festival's Talent Lab. Before all of that, Clara started out as an actor, training in Meisner with the late Jacqueline McClintock, studying scene study and script analysis with Larry Moss, and performing improv at UCB in Los Angeles and Toronto's Second City. She credits her love of story and character to her extensive training as an actor, and brings those experiences into her writing and directing work. In this episode, Amanda and Clara discuss the shift from actor to writer/director, how she got started in writing for TV, and how she navigates the pressures of comparison and self-doubt in the entertainment industry. Mentions from this episode… ~ This is John (short film by Jay & Mark Duplass) ~ Sleep Away (short film by Clara Altimas)  ~ Christmas Green (short film by Clara Altimas)  ~ Allan (Al) Magee  ~ Heated Rivalry (series)   Terms we mentioned… ~ “Meisner” - an acting approach developed by Sanford Meisner that focuses on "living truthfully under imaginary circumstances" ~ “Save the Cat” - a popular script writing book by Blake Snyder ~ “Punch up” - a term used to describe the process of adding more/better jokes to a script, or sharpening/heightening the existing jokes in a script ~ “Canadian Film Centre (CFC)” - https://cfccreates.com/ ~ “TIFF” - stands for the Toronto International Film Festival, one of the world's largest and most prestigious public-facing film festivals   ~ ~ ~ ~ ~   Let's Connect!  Liquid Courage - click here!  Amanda Pereira (host) - click here!  Clara Altimas (guest) - click here!    ⇒ To donate to the show, click here!   ~ ~ ~ ~ ~   The music in this episode is thanks to HookSounds. You can check out their tracks here: www.hooksounds.com. Use the discount code LIQUIDCOURAGE10 for 10% off a HookSounds subscription!* *If you use this code, I earn a small commission — so you'll be supporting the podcast, too!

Cat and Pat have a lot to discuss this week: Remembering the concept of "All You Cans", Pat's latest yoga venture, Cat's trip to New Orleans, The Real Housewives of Beverly Hills, the new Vanderpump Rules, and how Primate (2025) made Pat think more about morality. Cat and Pat send love to all of the 30 during these difficult and dark times. Sending some links below to current resources to learn more, donate, and take action:Minnesota Resources During ICE Operations Resource Guide for Community LeadersImmigrants Are Los AngelesNational Immigration Law CenterWatch the full episode on our YouTube and follow below!Show Instagram: https://www.instagram.com/seektreatmentpodShow Tiktok: https://www.tiktok.com/@seektreatmentpodCat: https://www.instagram.com/catccohenPat: https://www.instagram.com/patreegsSeek Treatment is a production of Headgum Studios. Our producer is Allie Kahan. Our executive producer is Emma Foley. The show is engineered and edited by Richelle Chen. The show art was created by Carly Jean Andrews.Like the show? Rate Seek Treatment on Spotify and Apple Podcasts and leave a review.Advertise on Seek Treatment via Gumball.fmSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Midlife isn't halfway to death. It's when you stop pretending. Your energy shifts. Your body changes. Your parents start aging. Your kids need you differently. The things that once felt like a huge deal… just aren't. Caring for aging parents changes you. Perspective shows up whether you asked for it or not.Tune in for new Cat & Nat Unfiltered episodes every Monday, Tuesday and Friday!Follow @catandnatunfiltered on Instagram: https://instagram.com/catandnatunfilteredCome see us LIVE on tour!! To see a full list of cities and dates, go to https://catandnattour.com.Are you a parent that is struggling understanding the online world, setting healthy screen-time limits, or navigating harmful online content? Purchase screen sense for $24.99 & unlock Cat & Nat's ultimate guide to parenting in the digital age. Go to https://www.thecommonparent.com/screen-sense-complete-guideFollow our parenting platform - The Common Parent - over on Instagram: https://instagram.com/thecommonparentMake sure you subscribe to our YouTube channel: https://bitly.com/catnatyoutubeGet personalized videos from us on Cameo: https://cameo.com/catandnatCome hang with us over on https://instagram.com/catandnat all day long.And follow us on https://tiktok.com/@catandnatofficial! Hosted on Acast. See acast.com/privacy for more information.

Miot, et al. v. Trump, et al., No. 25-cv-02471 (D.D.C. Feb. 2, 2026)TPS for Haiti; pretextual termination of TPS; INA § 242(f); APA vacatur and set aside; APA stay; equal protection; McNary; using public statements in litigation Matter of G-M-I-, 29 I&N Dec. 431 (BIA 2026)reliability and persuasiveness of expert testimony; factual basis for expert opinion; CAT; imprisonment for drugs; China Matter of Yadav, 29 I&N Dec. 438 (BIA 2026)sua sponte reopening based on marriage to a U.S. citizen; equities acquired after removal order Michelin, et al. v. Warden Moshannon Valley Correctional Center, et al., No. 24-2990 (3d Cir. Feb. 2, 2026)EAJA; habeas; sovereign immunity canon; civil action; importance of habeas; unreasonable prolonged detention  Montejo-Gonzalez, et al. v. Bondi, No. 21-304 (9th Cir. Feb. 5, 2026) (en banc)in absentia motion to reopen based on exceptional circumstances; unconscionable result; totality of the circumstances; traffic accidents; motivation to attend hearing Pinilla Perez v. Bondi, No. 23-6363 (2d Cir. Feb. 5, 2026)equitable tolling; reopening; OIL admission that N.Y. Penal Law § 220.39(1) attempted sale of cocaine is not a removable offense; Minter; N.Y. Crim. Proc. § 440.10(1)(k); change of law; reasonable diligence of removed noncitizensKurzban Kurzban Tetzeli and Pratt P.A.Immigration, serious injury, and business lawyers serving clients in Florida, California, and all over the world for over 40 years. Gonzales & Gonzales Immigration BondsP: (833) 409-9200immigrationbond.com  EB-5 Support"EB-5 Support is an ongoing mentorship and resource platform created specifically for immigration attorneys."Contact: info@eb-5support.comWebsite: https://eb-5support.com/Stafi"Remote staffing solutions for businesses of all sizes"Click me!The Pen and SwordClick me!Discount code: ImmigrationReview26 Want to become a patron?Click here to check out our Patreon Page!CONTACT INFORMATION:Email: kgregg@kktplaw.comFacebook: @immigrationreviewInstagram: @immigrationreviewTwitter: @immreviewAbout your hostCase notesRecent criminal-immigration article (p.18)Featured in San Diego VoyagerSupport the show

Double Tap - Ep 448 This episode of Double Tap is brought to you by: Primary Arms Night Fision (Code: WLSISLIFE) Otis Technology (Code: WELIKESHOOTING15) Second Call Defense Mitchell Defense (Code: WLS10) Swampfox Optics Text Dear WLS or Reviews +1 743 500 2171 New Public notes page. DEAR WLS Question from Dependable Don Hey bob what's it going to take to get a couple Gideon optics in ace vr….. I know your listening make it happen and the fans will try to stop Aaron from doing a over the pants handy Question from Duke of Crude from Texas Duke of Crude: Why is 28 gauge becoming more popular than 16 gauge? I ve been dabbling into shotguns recently and have noticed a large amount of 28 gauge availability even at places like Walmart. Notes: Savage is now Jar Jar binks with his stupid ass avatars he uses on the show to match some of the stupid ass comments he says. Also this being written in January, will Aaron go through more jobs, relationships, or vehicles in 2026? Question from Anonymous Coward from Florida Hi. Could y'all explain the legal process of building an sbr at home? I asked a local shop about doing the paperwork through them just to make it simple and their $200 fee, while probably reasonable, kind of put a damper on my excitement for free tax stamps. I know I need to get fingerprints and pictures done and engrave my address on the gun. What are my best options for accomplishing those things myself? Question from Anonymous Coward from Nebraska Dear wls. I have a bolt action 6.5 creedmoor pistol if I SBR it and for whatever reason want to unsbr it what would I have to do? Question from Anonymous Coward from NC Question for the cast from RealDeal Episode 644 got me thinking about printing suppressors. What if a company sold you a mounting device, either direct thread or QD, that is made of a material that can handle the heat. Then that company will sell along with it a STL file that allows you a certain number of prints or unlimited prints of the actual baffles/can. It would thread onto the mount that is on your gun and you could print an unlimited number of replacement “cans”. Just a thought that popped in. Also the only serialized part would be the mount. So you can just throw away the printed portion and slap on a new one. Let me know your thoughts. #textwhiledriving #agency171 #wls Question from Jaqin Ta'Sox from CT From Jaqin Ta'Sox: Question: Can you choose the order that the episodes are loaded into podcasts or is my app screwing with me? I ask because I'll listen to an episode with a guest, the listen to the following episode in the app and it says we have a guest in the next show. I feel like it keeps spoiling the surprise. Life full of spoilers. GUN INDUSTRY NEWS FN America Strike 9mm PCC with P90 Chassis and Polymer FSA Stocks at SHOT 2026 FN America unveiled the Strike 9mm pistol caliber carbine (PCC) at SHOT 2026, featuring a chassis compatible with the P90 magazine and modular polymer folding stocks from FN's Fast-Attachable Stock (FSA) lineup. The Strike PCC is designed for reliability and modularity, accepting P90 magazines for 9mm ammunition. Additional FSA stocks were shown for polymer construction, enhancing customization options. Shell-Tech Launches Shell-Tech Gear Shell-Tech has introduced Shell-Tech Gear, a new line of products aimed at the firearms and shooting industry. The launch was announced on February 2026 via Shooting Wire. Specific details on the gear's design and functionality were highlighted in the release. SHOT Show 2026: Small Players Deserving Recognition The article highlights lesser-known exhibitors at SHOT Show 2026 who introduced innovative firearms industry products and technologies. It emphasizes companies making significant contributions despite their smaller scale. These shout-outs aim to draw attention to emerging players in the market. Holosun Announces New Optics Lineup for 2026 Holosun has unveiled several new red dot sights and enclosed emitters targeted at pistol, rifle, and tactical users for release in 2026. Key models include updates to the EPS and SCS series with improved durability and multi-reticle options. These optics emphasize solar power integration and ruggedized housings for competitive and duty use. Hornady Announces Dates for 2026 Zombies in the Heartland 3-Gun Match Hornady has announced the dates for the 2026 Zombies in the Heartland 3-Gun Match, a multi-gun shooting competition. The event continues the series focused on 3-gun disciplines. Specific dates and location details are provided in the announcement. Palmetto State Armory PSA Sabre MK-12 Mod-O Long Range Build Palmetto State Armory details the PSA Sabre MK-12 Mod-O, a long-range AR-15 build designed for precision shooting at distances up to 800 yards. The rifle features a 18-inch stainless steel barrel with a 1:7 twist rate, mid-length gas system, and B5 Systems furniture for enhanced accuracy and control. It incorporates PSA's custom components including the Sabre lower receiver and JAKL-compatible upper for optimal performance. SHOT 2026: Taurus TX9 Judge 20th Anniversary Wood Home Defender Taurus unveiled the TX9 Judge 20th Anniversary Wood Home Defender at SHOT 2026, commemorating 20 years of the Judge revolver line. This special edition features a wood furniture aesthetic tailored for home defense applications. It builds on the compact TX9 platform with anniversary-specific customizations. Vortex Triumph Red Dot Sight Vortex Optics has released the Triumph, an ultra-affordable red dot sight designed for everyday carry and range use. It features a 3 MOA dot, 50,000-hour battery life, and fully multi-coated lenses in a lightweight, durable aluminum housing. The sight is optimized for pistols and carbines with a low-profile mount. Smith & Wesson Field Ethos Model 36 DAO No-Lock .38 Spl Snubnose Smith & Wesson has released the Field Ethos Model 36, a double-action-only snubnose revolver chambered in .38 Special without an internal lock mechanism. It features a 3-inch barrel and is designed for field carry with enhanced durability. The revolver emphasizes reliability and simplicity for everyday defense. Beretta B22 Jaguar Product Preview at SHOT 2026 Beretta unveiled the B22 Jaguar, a new rimfire rifle, at SHOT 2026, designed from the ground up with modern features for precision shooting. The rifle incorporates advanced ergonomics and customizable components tailored for competitive and recreational shooters. It represents Beretta's entry into the growing .22LR market segment with innovative engineering. Caldwell Claycopter Shotgun Targets Announced for SHOT Show 2026 Caldwell has unveiled the Claycopter, a new line of remote-controlled shotgun targets for SHOT Show 2026. These drone-based clay targets simulate realistic bird flight patterns for trap, skeet, and sporting clays practice. The product aims to enhance shotgun training with programmable flight paths and app integration. US PALM Storm Series CAT-4 Rifles Enter AR Market at SHOT 2026 US PALM has introduced the Storm Series CAT-4 rifles, a new line of AR-platform firearms showcased at SHOT 2026. These rifles feature a proprietary CAT-4 operating system designed for enhanced reliability and performance in the AR market. The series targets enthusiasts seeking innovative alternatives to traditional AR designs. SnakeStaff Systems Product Introduction SnakeStaff Systems is featured in industry news with a focus on their tactical products. The article highlights their offerings without specifying individual model details or release timelines. Content centers on the company's presence in the firearms and tactical equipment sector. Vortex Triumph Red Red Dot Sight Vortex Optics has released the Triumph Red, a compact open reflex red dot sight designed for everyday carry and concealed firearms. It features a 3 MOA dot, auto-brightness adjustment, and a lightweight polymer housing. The sight is optimized for pistols and micro-compact platforms with a low-profile mount. Trijicon Unveils New Hunting Optics Lineup for 2026 Trijicon has released a series of new hunting optics designed for big game hunters, featuring enhanced low-light performance and rugged durability. The lineup includes riflescopes, red dots, and binoculars tailored for various hunting scenarios from close-quarters to long-range. These optics emphasize Trijicon's signature illuminated reticles and premium glass quality. Roswell Rifle Works Unveils US-Made SR-3M Vikhr at SHOT 2026 Roswell Rifle Works has introduced a fully US-made version of the Russian SR-3M Vikhr submachine gun at SHOT 2026. The rifle replicates the compact, high-velocity design with 9mm and .300 Blackout chamberings. It features a short 5.56x30mm-inspired round at 850 m/s muzzle velocity, emphasizing domestic production. Arktis Unveils Multispectral Camouflage Cloak at SHOT Show 2026 Arktis introduced their new multispectral camouflage cloak at SHOT Show 2026, designed for advanced concealment across visual, near-infrared, and thermal spectra. The lightweight, packable design targets military and tactical users seeking superior low-observable performance. It builds on Arktis' expertise in adaptive camouflage systems. Walmart Liable for Gun Sale to Suicidal Employee in Jury Verdict A federal jury found Walmart liable for negligently selling a handgun to a suicidal employee who later used it to commit suicide. The case hinged on claims that Walmart failed to properly train staff to recognize warning signs during the purchase. The verdict awards $1 million to the victim's family, raising questions about retailer responsibilities in firearm sales. Zenith Firearms Unveils ZF-9 and ZF-10 MRDS PDW Pistols at SHOT 2026 Zenith Firearms introduced the ZF-9 and ZF-10, a pair of compact MRDS-ready PDW pistols chambered in 9mm and 10mm, respectively, at SHOT 2026.

Dear Listener, are you a late-in-life virgin feeling broken, behind, or like something is fundamentally wrong with you? Do you avoid dating altogether because you dread the moment you'd have to disclose your virginity? If virgin shame is keeping you stuck in isolation — and making partnered sex that much less likely — you're in the right place.In this episode, we welcome back Relationship Center psychotherapist and sex therapist Cat Fillmore to explore how to date as a virgin with confidence, self-compassion, and hope.Cat starts by reframing the conversation entirely: What does "virgin" even mean, and who decided? She challenges the narrow definition most of us inherited and invites us toward something more liberating.From there, we dive into practical late bloomer dating advice. Cat explains why the skills that make for great sex aren't actually about experience—and how you can start developing them right now. She shares a "yes, no, maybe" framework for building confidence with boundaries, an essential part of pleasurable sex. We also tackle the big question: should I tell them I'm a virgin, and when? Cat explains how to recognize when someone has earned the honor of your vulnerability—and what to look for before you share.Finally, Cat offers a reality check for anyone struggling to overcome virgin stigma. Spoiler alert: The data might surprise you—you're far from alone as a late bloomer.If shame has been keeping you on the sidelines, this episode offers a compassionate, empowering path forward.Key Takeaways00:00 Intro01:30 What does it even mean to be a virgin?07:38 How do I date as a late-in-life virgin?18:31 Should I tell my date I'm a virgin—and when?30:14 How do I stop feeling broken or behind as a late-in-life virgin?Have a question or comment? Email us at podcast@relationshipcenter.com. We love hearing from you!If you'd like to work with one of the talented clinicians on our team (including Cat!), go to relationshipcenter.com/apply-now to apply for a free 30-minute consultation.To get a monthly email with our best content, go to relationshipcenter.com/newsletter.If something in this episode touched you, will you share it with a friend? That helps us reach more sweet humans like you.Lastly, we'd love it if you would leave us a rating and review wherever you listen to podcasts. And be sure to hit subscribe while you're there so you never miss an episode!

喜歡張大春主持的「聽說張大春」嗎？歡迎小額贊助我們，讓我們繼續產出優質節目＞https://open.firstory.me/join/thehearsayzhangdachun 主持人：張大春 來賓：資深樂評人袁永興 主題：娛樂轟趴｜動物之歌 本集播出日期：2021.01.13 播放曲目： 1. Baby Shark 2. L'Elefante e la Farfalla / Michele Zarrillo 3. Me and You and a Dog Named Boo / Lobo 4. Cat's in the Cradle / Harry Chapin 5. A Horse With No Name / America 6. She Wolf / Shakira 7. Bird On A Wire / Neville Brothers 8. Fly Like an Eagle / Steve Miller 9. El Condor Pasa (If I Could) / Simon & Garfunkel 10. Union of the Snake / Duran Duran ----- ▍聽更多：https://flow.page/thehearsay ▍粉絲團：https://www.facebook.com/TheHearSayChannel ▍合作贊助：thehearsaytw@gmail.com Powered by Firstory Hosting

There is a shift in parenting older kids. The roles, the routines, even the purpose. Do we need a club? Hobbies? A retirement home for people our age? We ask ourselves the three questions every mom should ask. Weigh in and let us know your answers!This podcast is presented by The Common Parent. The all-in-one parenting resource you need to for your teens & tweens. We've uncovered every parenting issue, so you don't have too.Are you a parent that is struggling understanding the online world, setting healthy screen-time limits, or navigating harmful online content? Purchase screen sense for $24.99 & unlock Cat & Nat's ultimate guide to parenting in the digital age. Go to https://www.thecommonparent.com/screen-sense-ebook Follow @thecommonparent on Instagram: https://www.instagram.com/thecommonparent/ Hosted on Acast. See acast.com/privacy for more information.

Jason Chapin is the son of Harry Chapin, one of the greatest recording artists of the 1970's with two of the biggest and most memorable hits of all time: Taxi and 1974's monumental hit Cat's in the Cradle.  Harry Chapin tragically died in 1981 in an auto accident in Long Island, NY. On the 50th anniversary of Cat's in the Cradle's hitting the charts as #1 on the Billboard Hot 100 for the week of December 21, 1974, Jason co-produced an award-winning documentary, Harry Chapin - Cat's In the Cradle: The Song that Changed Our Lives.  Included in the film are musical giants like Billy Joel, Judy Collins, Pat Benatar, Dee Snider, Mandy Patinkin & others who weigh in on Harry's legacy. These iconic lyrics from the chorus are among the most famous from any song in history: And the cat's in the cradle and the silver spoon Little Boy Blue and the man in the moon "When you comin' home, dad?" "I don't know when, but we'll get together then You know we'll have a good time then." We discuss: -Why now with a documentary in the 50th anniversary of the song. -Who was the child that arrived? -How did Harry steal the song from his wife? -What do you suppose your mom Sandy Chapin meant by “We don't know life's lessons until too late?” - Which part of the 60% in Taxi that is true is actually true? -Judy Colins - "Harry had lyrically the human touch. Genius of putting scenes together that happened in real life." -Billy Joel - "It was all about humanity.  Not politics, but what it's like to be a human & the foibles & failure & struggles."    

What Matters Most When Opening a Coffee Shop- and Where to Spend Your Money - Episode #436 Cat & Cloud Coffee www.catandcloud.com/ Summary Thinking about opening a coffee shop? Here's where your money actually matters—and where it doesn't. In this episode, Chris Baca and Jared Truby…aka Dale ;) unpack what actually matters when you're opening (or refreshing) a café: create a real feeling of place without overspending on flashy build-out, “blow the bag” on the essentials (espresso machine, grinders, and water filtration), and don't get distracted by optional prestige projects like roasting, direct trade, or origin travel before the core experience is dialed. They also zoom out on how café design has evolved since early third-wave homogeneity and land on a grounded definition of “sustaining excellence”: either innovate with intention or “plus the show” by obsessively maintaining the details that signal care—because culture is what people learn to accept as normal. Chapters 00:00 Monterey and Coffee 07:00 Opening a New Coffee Shop? 13:30 Business reflects the people who started it 21:00 Should I Roast Myself? 29:00 Homogeny in Coffee Shop Design 33:20 What's Worth It vs. What's Hype 42:00 Plus the Show Cat & Cloud: Instagram www.instagram.com/catcloudcoffee/ Webstore www.catandcloud.com/ We LOVE our Wholesale Partners! Interested in serving our coffee at your business? Learn more about our Partner Program https://catandcloud.com/pages/wholesale Links – Six Over Coffee https://www.instagram.com/sixovercoffee/?hl=en Cat & Cloud Coffee was founded in 2016 by three friends who believe experiences and connections shape our lives. Former barista champions and lifelong coffee professionals, they envisioned a better way to do business and set out to create a values-driven organization that put culture first. Our mission is to inspire connection by creating memorable experiences. Whether it's with guests in our 4 retail locations in Santa Cruz, our team members, or our wholesale partners across the country, we strive to leave everyone better than we found them. The Cat & Cloud Podcast is a space for us to share our experiences and adventures in coffee and business in hopes of inspiring more people to create culture and values-driven organizations.

Remember when you were young and had a crush...you hung out with the same friend group, drank a bit, made out a little, and suddenly you were together. Basically, if you were talking to someone, you were dating them. Fast forward to today and we genuinely don't understand the rules anymore. If we were single and dating a man our age (or younger!), we'd 100% still be playing by the old-fashioned rules. The question is, would he be doing the same!?Tune in for new Cat & Nat Unfiltered episodes every Monday, Tuesday and Friday!Follow @catandnatunfiltered on Instagram: https://instagram.com/catandnatunfilteredCome see us LIVE on tour!! To see a full list of cities and dates, go to https://catandnattour.com.Are you a parent that is struggling understanding the online world, setting healthy screen-time limits, or navigating harmful online content? Purchase screen sense for $24.99 & unlock Cat & Nat's ultimate guide to parenting in the digital age. Go to https://www.thecommonparent.com/screen-sense-complete-guideFollow our parenting platform - The Common Parent - over on Instagram: https://instagram.com/thecommonparentMake sure you subscribe to our YouTube channel: https://bitly.com/catnatyoutubeGet personalized videos from us on Cameo: https://cameo.com/catandnatCome hang with us over on https://instagram.com/catandnat all day long.And follow us on https://tiktok.com/@catandnatofficial! Hosted on Acast. See acast.com/privacy for more information.